Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	SETX MYO9B ABCA12 KIF24 DDX10 UBA7 MYO3B SHPRH CHD6 ACSS3 DDX31 TCP1 MYO1H IDE SMARCA2 MACF1 ABCC12 ATP12A MYO15A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.88e-07	614	213	23	GO:0140657
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.92e-06	11	213	4	GO:0005388
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2 RYR3	4.75e-06	4	213	3	GO:0005219
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	SLC24A3 RYR1 RYR2 RYR3 CACNA1A RIMBP2 ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.23e-06	151	213	10	GO:0015085
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2 RYR3	2.34e-05	6	213	3	GO:0048763
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.79e-05	36	213	5	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.79e-05	36	213	5	GO:0015662
GeneOntologyMolecularFunction	calmodulin binding	MYO9B RYR1 RYR2 RYR3 CACNA1A MYO15A ATP2B1 ATP2B2 ATP2B3 ATP2B4 PCNT	3.84e-05	230	213	11	GO:0005516
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity	HS3ST3B1 HS3ST3A1	1.13e-04	2	213	2	GO:0033872
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA12 ABCC12 ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.69e-04	109	213	7	GO:0042626
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYO9B ABCA12 DDX10 CHD6 DDX31 TCP1 IDE MACF1 ABCC12 ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.91e-04	441	213	14	GO:0016887
GeneOntologyMolecularFunction	platelet-derived growth factor receptor activity	PDGFRA PDGFRB	3.37e-04	3	213	2	GO:0005017
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	KCNH7 SLC24A3 RYR1 RYR2 RYR3 CACNA1A SLC10A5 RIMBP2 ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4 SLC6A14	4.93e-04	465	213	14	GO:0046873
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.20e-04	62	213	5	GO:0019829
GeneOntologyMolecularFunction	histone binding	SSRP1 PSME4 MLLT3 CHD6 PRMT7 NCAPD3 USP16 SBNO2 SBNO1 SMARCA2	5.80e-04	265	213	10	GO:0042393
GeneOntologyMolecularFunction	actin binding	MAP1A MYO9B FMN1 MYO3B FLNB FLNC SYNE1 MYO1H MICAL2 MACF1 FHDC1 SSH2 MYO15A MYBPC3	6.60e-04	479	213	14	GO:0003779
GeneOntologyMolecularFunction	microfilament motor activity	MYO9B MYO3B MYO1H MYO15A	6.99e-04	38	213	4	GO:0000146
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR1 RYR2 RYR3	8.68e-04	18	213	3	GO:0015278
GeneOntologyBiologicalProcess	regulation of cytosolic calcium ion concentration	RYR1 RYR2 PLCD1 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.35e-06	84	211	8	GO:0051480
GeneOntologyBiologicalProcess	regulation of cardiac conduction	RYR2 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.04e-05	29	211	5	GO:1903779
HumanPheno	Abnormal cardiological findings	DBH RYR1 DES AARS2 CACNA1A FLNC NRAS TMEM43 MRPL39 POLG2 MYBPC3	2.87e-05	178	71	11	HP:0003114
HumanPheno	Abnormal cardiac test	DBH RYR1 DES AARS2 CACNA1A FLNC NRAS TMEM43 MRPL39 POLG2 MYBPC3	3.02e-05	179	71	11	HP:0500015
HumanPheno	Abnormal test result	DBH RYR1 DES AARS2 CACNA1A FLNC NRAS TMEM43 MRPL39 POLG2 MYBPC3	3.35e-05	181	71	11	HP:0500014
HumanPheno	Fatigable weakness	RYR1 CHRND DES NEK1 ATXN2 FLNC SYNE1 OPTN AGRN	3.85e-05	121	71	9	HP:0003473
HumanPheno	Abnormal synaptic transmission at the neuromuscular junction	RYR1 CHRND DES NEK1 ATXN2 FLNC SYNE1 OPTN AGRN	4.11e-05	122	71	9	HP:0003398
HumanPheno	Abnormal peripheral nervous system synaptic transmission	RYR1 CHRND DES NEK1 ATXN2 FLNC SYNE1 OPTN AGRN	4.11e-05	122	71	9	HP:0030191
HumanPheno	Abnormal synaptic transmission	RYR1 CHRND DES NEK1 ATXN2 FLNC SYNE1 OPTN AGRN	4.11e-05	122	71	9	HP:0012535
HumanPheno	Broad nasal tip	RYR1 NEK1 PRMT7 FLNB NRAS WASHC4 EXOSC2 ASXL3 SETBP1 LAS1L	5.92e-05	159	71	10	HP:0000455
HumanPheno	Abnormality of the larynx	PDGFRA MDH2 RYR1 CHRND NEK1 ATXN2 VPS13A HERC2 PRMT7 FLNB FRAS1 DYNC2I2 SYNE1 CAT TMEM43 OPTN KMT2D AOPEP ASXL3 SETBP1 AGRN PCNT	5.99e-05	666	71	22	HP:0001600
HumanPheno	Supraventricular arrhythmia	DBH RYR1 RYR2 DES FLNC NRAS SYNE1 TMEM43 POLG2	8.61e-05	134	71	9	HP:0005115
HumanPheno	Abnormal larynx morphology	MDH2 NEK1 PRMT7 FLNB FRAS1 DYNC2I2 SYNE1 TMEM43 ASXL3 SETBP1 PCNT	8.78e-05	201	71	11	HP:0025423
HumanPheno	Orthopnea	CHRND DES NEK1 ATXN2 FLNC OPTN AGRN MYBPC3	1.11e-04	108	71	8	HP:0012764
HumanPheno	Fatigable weakness of respiratory muscles	CHRND DES NEK1 ATXN2 OPTN AGRN	1.35e-04	58	71	6	HP:0030196
HumanPheno	Abnormal knee physiology	PDGFRB RYR1 FLNB FLNC NRAS SYNE1 CTDP1	1.82e-04	87	71	7	HP:0034670
HumanPheno	Abnormality of the shoulder girdle musculature	RYR1 RYR3 CHRND FLNB FLNC SYNE1 TMEM43 POLG2 AGRN	1.95e-04	149	71	9	HP:0001435
HumanPheno	Abnormality of the upper respiratory tract	PDGFRA PDGFRB MDH2 FCHO1 RYR1 CHRND NEK1 ATXN2 VPS13A CHD6 HERC2 PRMT7 CACNA1A FLNB FRAS1 DYNC2I2 SYNE1 CAT TMEM43 RFX5 OPTN KMT2D AOPEP ASXL3 SETBP1 SMARCA2 AGRN SLC6A14 PCNT	2.14e-04	1111	71	29	HP:0002087
HumanPheno	Upper limb muscle weakness	RYR1 CHRND NEK1 ATXN2 FLNC SYNE1 TMEM43 OPTN AGRN	2.16e-04	151	71	9	HP:0003484
HumanPheno	Proximal muscle weakness in lower limbs	RYR1 DES NEK1 ATXN2 FLNC SYNE1 TMEM43 OPTN POLG2 SORD	2.20e-04	186	71	10	HP:0008994
HumanPheno	Abnormal nasal dorsum morphology	PDGFRB ABCA12 CHRND BUB1B CHD6 PRMT7 NRAS EXOSC2 KMT2D SMARCA2 SPEN PCNT	2.24e-04	262	71	12	HP:0011119
HumanPheno	Tibial bowing	PDGFRB FLNB FN1 SETBP1 PCNT	2.32e-04	41	71	5	HP:0002982
HumanPheno	Atrioventricular block	RYR2 DES FLNC SYNE1 TMEM43 LARS2 MYBPC3	2.77e-04	93	71	7	HP:0001678
HumanPheno	Heart block	RYR2 DES FLNC SYNE1 TMEM43 LARS2 MYBPC3	2.77e-04	93	71	7	HP:0001668
MousePheno	abnormal paired-pulse inhibition	PCDH17 CACNA1A RIMBP2 AGRN	2.48e-06	9	169	4	MP:0004807
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.52e-08	4	209	4	IPR022141
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.52e-08	4	209	4	PF12424
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.52e-08	4	209	4	IPR006408
Domain	ATPase_P-typ_TM_dom	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.61e-07	16	209	5	IPR023298
Domain	-	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.61e-07	16	209	5	1.20.1110.10
Domain	ATPase_P-typ_cation-transptr_C	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.28e-07	17	209	5	IPR006068
Domain	Cation_ATPase_C	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.28e-07	17	209	5	PF00689
Domain	Cation_ATPase_N	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.27e-06	18	209	5	PF00690
Domain	Cation_ATPase_N	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.27e-06	18	209	5	SM00831
Domain	Ryanodine_rcpt	RYR1 RYR2 RYR3	1.38e-06	3	209	3	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2 RYR3	1.38e-06	3	209	3	IPR009460
Domain	RyR	RYR1 RYR2 RYR3	1.38e-06	3	209	3	PF02026
Domain	RR_TM4-6	RYR1 RYR2 RYR3	1.38e-06	3	209	3	PF06459
Domain	Ryan_recept	RYR1 RYR2 RYR3	1.38e-06	3	209	3	IPR013333
Domain	ATPase_P-typ_cation-transptr_N	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.71e-06	19	209	5	IPR004014
Domain	RIH_assoc-dom	RYR1 RYR2 RYR3	2.69e-05	6	209	3	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2 RYR3	2.69e-05	6	209	3	PF08709
Domain	RIH_assoc	RYR1 RYR2 RYR3	2.69e-05	6	209	3	PF08454
Domain	RIH_dom	RYR1 RYR2 RYR3	2.69e-05	6	209	3	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2 RYR3	2.69e-05	6	209	3	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2 RYR3	2.69e-05	6	209	3	IPR015925
Domain	-	RYR1 RYR2 RYR3	2.69e-05	6	209	3	1.25.10.30
Domain	Tyr_kinase_CSF1/PDGF_rcpt	PDGFRA PDGFRB NPTN	2.69e-05	6	209	3	IPR016243
Domain	RYDR_ITPR	RYR1 RYR2 RYR3	2.69e-05	6	209	3	PF01365
Domain	ATPase_P-typ_cyto_domN	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.13e-05	35	209	5	IPR023299
Domain	ATPase_P-typ_P_site	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.75e-05	36	209	5	IPR018303
Domain	P_typ_ATPase	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.75e-05	36	209	5	IPR001757
Domain	ATPASE_E1_E2	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.75e-05	36	209	5	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.45e-05	37	209	5	IPR008250
Domain	E1-E2_ATPase	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.45e-05	37	209	5	PF00122
Domain	CH	EHBP1L1 FLNB FLNC SYNE1 MICAL2 MACF1	8.71e-05	65	209	6	SM00033
Domain	ACTININ_2	FLNB FLNC SYNE1 MACF1	1.14e-04	23	209	4	PS00020
Domain	ACTININ_1	FLNB FLNC SYNE1 MACF1	1.14e-04	23	209	4	PS00019
Domain	Actinin_actin-bd_CS	FLNB FLNC SYNE1 MACF1	1.14e-04	23	209	4	IPR001589
Domain	SNO	SBNO2 SBNO1	1.25e-04	2	209	2	IPR026741
Domain	Basigin	BSG NPTN	1.25e-04	2	209	2	IPR009151
Domain	SBNO_Helicase_C_dom	SBNO2 SBNO1	1.25e-04	2	209	2	IPR026937
Domain	Caskin_C	CASKIN2 CASKIN1	1.25e-04	2	209	2	IPR032117
Domain	PP1_bind	CDCA2 MKI67	1.25e-04	2	209	2	PF15276
Domain	Helicase_C_4	SBNO2 SBNO1	1.25e-04	2	209	2	PF13871
Domain	PP1-bd	CDCA2 MKI67	1.25e-04	2	209	2	IPR029334
Domain	Caskin-tail	CASKIN2 CASKIN1	1.25e-04	2	209	2	PF16632
Domain	ATP2B1/4	ATP2B1 ATP2B4	1.25e-04	2	209	2	IPR030319
Domain	CH	EHBP1L1 FLNB FLNC SYNE1 MICAL2 MACF1	1.32e-04	70	209	6	PF00307
Domain	-	EHBP1L1 FLNB FLNC SYNE1 MICAL2 MACF1	1.43e-04	71	209	6	1.10.418.10
Domain	MIR	RYR1 RYR2 RYR3	1.56e-04	10	209	3	PF02815
Domain	MIR_motif	RYR1 RYR2 RYR3	1.56e-04	10	209	3	IPR016093
Domain	MIR	RYR1 RYR2 RYR3	1.56e-04	10	209	3	PS50919
Domain	MIR	RYR1 RYR2 RYR3	1.56e-04	10	209	3	SM00472
Domain	CH	EHBP1L1 FLNB FLNC SYNE1 MICAL2 MACF1	1.67e-04	73	209	6	PS50021
Domain	CH-domain	EHBP1L1 FLNB FLNC SYNE1 MICAL2 MACF1	1.94e-04	75	209	6	IPR001715
Domain	HAD-like_dom	CTDP1 ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.58e-04	79	209	6	IPR023214
Domain	DUF4217	DDX10 DDX31	7.37e-04	4	209	2	PF13959
Domain	DUF4217	DDX10 DDX31	7.37e-04	4	209	2	SM01178
Domain	DUF4217	DDX10 DDX31	7.37e-04	4	209	2	IPR025313
Domain	BRK	CHD6 SMARCA2	1.81e-03	6	209	2	SM00592
Domain	SPOC_C	PHF3 SPEN	1.81e-03	6	209	2	IPR012921
Domain	BRK_domain	CHD6 SMARCA2	1.81e-03	6	209	2	IPR006576
Domain	BRK	CHD6 SMARCA2	1.81e-03	6	209	2	PF07533
Domain	SPOC	PHF3 SPEN	1.81e-03	6	209	2	PF07744
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	PDGFRA PDGFRB RYR1 RYR2 RYR3 PLCD1 CACNA1A P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.33e-07	178	153	12	M2890
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.79e-06	54	153	7	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.79e-06	54	153	7	MM15202
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR1 RYR2 RYR3 CACNA1A	4.15e-06	11	153	4	M47958
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.17e-06	12	153	4	M27326
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.39e-06	27	153	5	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.13e-05	28	153	5	M924
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.23e-05	14	153	4	MM15052
Pathway	REACTOME_MUSCLE_CONTRACTION	RYR1 RYR2 RYR3 DES ATP2B1 ATP2B2 ATP2B3 ATP2B4 MYBPC3	7.83e-05	165	153	9	MM15026
Pathway	REACTOME_CARDIAC_CONDUCTION	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.28e-04	103	153	7	MM15196
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR1 RYR2 RYR3 CACNA1A RGS6 ATP2B1 ATP2B2 ATP2B3	2.00e-04	147	153	8	MM15854
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR1 RYR2 RYR3 CACNA1A RGS6 ATP2B1 ATP2B2 ATP2B3	2.40e-04	151	153	8	M39329
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	HS3ST3B1 HS3ST3A1 VCAN B3GAT1 AGRN	2.91e-04	54	153	5	MM14633
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.17e-04	55	153	5	M971
Pathway	WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING	RYR1 RYR2 RYR3	3.31e-04	13	153	3	M39589
Pathway	REACTOME_MUSCLE_CONTRACTION	RYR1 RYR2 RYR3 DES ATP2B1 ATP2B2 ATP2B3 ATP2B4 MYBPC3	3.72e-04	203	153	9	M5485
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.75e-04	57	153	5	MM15643
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	HS3ST3B1 HS3ST3A1 VCAN B3GAT1 AGRN	3.75e-04	57	153	5	M692
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY	PDGFRA PDGFRB NRAS	5.18e-04	15	153	3	M47535
Pathway	REACTOME_CARDIAC_CONDUCTION	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.36e-04	130	153	7	M27454
Pathway	WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION	ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.00e-04	36	153	4	M39831
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	RYR1 RYR2 RYR3 ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.70e-04	176	153	8	MM15718
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETX HK2 MYO9B SRM SSRP1 DDX10 CDCA2 PSME4 RBM19 RPTOR A2ML1 MKI67 HERC2 WDR13 FLNB FLNC WASHC4 FN1 TCP1 EML4 HNRNPA3 CAT USP16 IGF2BP2 ARAP3 MTHFD1 MICAL2 SMARCA2 MACF1 TANC1 LAS1L ATP2B1 AGRN RPL13 SORD	7.54e-13	1353	215	35	29467282
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	RYR1 RYR2 RYR3 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4	7.80e-11	38	215	8	30786075
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SETX PDGFRA TEX2 GIGYF1 SSRP1 CEP170 CDCA2 NEK4 NEK1 CASKIN2 RPTOR BUB1B OSBPL8 MAP3K10 ALPK1 INPP5F CARD8 ARFGEF3 OPTN PHF3 MACF1 TANC1 SSH2 CKAP2 ATP2B1	1.80e-10	861	215	25	36931259
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	12209837
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	8245032
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	7989379
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	36130203
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	10577388
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	8634322
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	12784250
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	11152753
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	10434059
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.42e-09	4	215	4	15101689
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETX TEX2 RCC2 PSME4 CASKIN2 RPTOR CASKIN1 RALGDS NCAPD3 RELCH WASHC4 FBF1 INPP5F SETBP1 CAPRIN2 PCNX1 HPS5 EXOSC7	6.53e-09	529	215	18	14621295
Pubmed	Differential regulation of the apical plasma membrane Ca(2+) -ATPase by protein kinase A in parotid acinar cells.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	7.07e-09	5	215	4	17938178
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ARID4B TEX2 MDH2 RCC2 CFB ATXN2 FMN1 CASKIN1 A2ML1 C3 CHD6 HERC2 CACNA1A THSD7A FN1 TCP1 CAT	8.33e-09	475	215	17	31040226
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	OSBPL8 CHD6 THSD7A SYNE1 PUM2 ALPK1 PHF3 SETBP1 MACF1 PCNX1 HPS5 PCNT	1.88e-08	225	215	12	12168954
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ECD MKRN2 SSRP1 RCC2 CEP170 ATXN2 BSG RBM19 MKI67 C3 FLNB RPS6KA4 TCP1 HNRNPA3 CAT TMEM43 USP16 EXOSC2 MRPL39 IGF2BP2 MTHFD1 PHF3 CKAP2 LAS1L SPEN EXOSC7 RPL13	2.08e-08	1257	215	27	36526897
Pubmed	Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.11e-08	6	215	4	12767889
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZBTB38 PDGFRB RYR3 ZNF331 PLEKHH1 UBA7 USP32 OSBPL8 MAP3K10 MLLT3 CHD6 HERC2 WDR13 PLXNB3 FLNB WASHC4 FN1 SYNE1 BTBD2 USP16 RFX5 SBNO1 MICAL2 MACF1 CKAP2 RPL13 PCNT	3.27e-08	1285	215	27	35914814
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ARID4B MYO9B SSRP1 RCC2 DDX10 CEP170 CDCA2 MKI67 HERC2 NCAPD3 DDX31 HNRNPA3 EXOSC2 IGF2BP2 PHF3 MACF1 CKAP2 LAS1L EXOSC7 RPL13	6.46e-08	759	215	20	35915203
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	ARID4B MYO9B SYTL2 KIF24 SVEP1 RYR1 AARS2 A2ML1 VPS13A HERC2 CACNA1A ALPK1 ARFGEF3 KMT2D ASXL3 TMEM209 ATP2B4	7.35e-08	552	215	17	10737800
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ECD SSRP1 MDH2 RYR2 CDCA2 DES BSG VPS13A CHD6 FLNB FLNC SYNE1 FBF1 HNRNPA3 CAT TMEM43 SBNO1 CAPRIN2 MACF1 ATP12A SPEN ATP2B1 ATP2B2 ATP2B3 SLC6A14 RPL13 PHTF1 PCNT	9.22e-08	1442	215	28	35575683
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.75e-08	8	215	4	10951186
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARID4B RYR1 RYR2 PLEKHH1 NEK4 EHBP1L1 VPS13A CHD6 ACSS3 NCAPD3 FBF1 IDE KMT2D ASXL3 SMARCA2 SPEN ATP2B1 ATP2B3	1.11e-07	638	215	18	31182584
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MYO9B SSRP1 MDH2 RCC2 DDX10 CEP170 AARS2 MKI67 HERC2 FLNB FLNC TCP1 SYNE1 HNRNPA3 CAT IGF2BP2 MTHFD1 MACF1 LAS1L SPEN ATP2B1 RPL13 PCNT	1.14e-07	1024	215	23	24711643
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RCC2 DDX10 CEP170 MKI67 OSBPL8 HERC2 FLNB FLNC DDX31 FN1 HNRNPA3 IGF2BP2 PHF3 SMARCA2 MACF1 LAS1L SPEN PCNT	1.56e-07	653	215	18	22586326
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TEX2 ECD SRM SSRP1 MDH2 DDX10 CASKIN2 BSG BUB1B VPS13A OSBPL8 SEMA6A HERC2 FRAS1 DDX31 SYNE1 USP16 MRPL39 TMEM209 MACF1 TANC1 CKAP2 LAS1L ATP2B1 ATP2B4 FAM177A1 RPL13 PCNT	1.73e-07	1487	215	28	33957083
Pubmed	Emergent mechanical control of vascular morphogenesis.	PDGFRA DES MKI67 FN1	1.75e-07	9	215	4	37566656
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	18403125
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	18434746
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2 RYR3	2.33e-07	3	215	3	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	21881589
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR2 RYR3	2.33e-07	3	215	3	12213830
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	25239916
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR2 RYR3	2.33e-07	3	215	3	11159936
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	7959768
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	7635066
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	7876312
Pubmed	A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation.	NPTN ATP2B1 ATP2B4	2.33e-07	3	215	3	28827723
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	10788707
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	7621815
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	10473538
Pubmed	Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.	RYR1 RYR3 CACNA1A	2.33e-07	3	215	3	18313230
Pubmed	Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.	NPTN ATP2B1 ATP2B2	2.33e-07	3	215	3	34948386
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	9242641
Pubmed	Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.	PDGFRA PDGFRB FN1	2.33e-07	3	215	3	24022915
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	18643873
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR2 RYR3	2.33e-07	3	215	3	4600883
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	VPS13A THSD7A INPP5F CARD8 SBNO2 PCNX1 HPS5 SPEN	2.49e-07	102	215	8	10231032
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MKRN2 FCHO1 CEP170 SYCP2 RBM19 FBF1 HNRNPA3 ARFGEF3 PHF3 ASXL3 MACF1 SPEN RPL13	4.64e-07	361	215	13	26167880
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SYTL2 FCHO1 CEP170 NEK1 AARS2 OSBPL8 PRMT7 RNF169 THSD7A ALPK1 HIVEP3 CNTNAP4 MACF1 FHDC1 SSH2	5.13e-07	493	215	15	15368895
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SETX NBPF26 SSRP1 RCC2 DDX10 ATXN2 RBM19 OSBPL8 CHD6 HERC2 NCAPD3 RNF169 DDX31 NRAS SYNE1 PUM2 EXOSC2 MTHFD1 PHF3 SMARCA2 MACF1 TANC1 CKAP2 LAS1L SPEN EXOSC7 AGRN	6.74e-07	1497	215	27	31527615
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CDCA2 ATXN2 CASKIN2 BSG VPS13A MKI67 HERC2 RELCH RNF169 DDX31 TCP1 IDE IGF2BP2 KMT2D TANC1 SSH2 CKAP2 ATP2B1 ATP2B4 RPL13 TTC33 PCNT	6.92e-07	1049	215	22	27880917
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP1A DDX10 CEP170 ATXN2 RBM19 MKI67 FLNC EML4 PUM2 USP16 EXOSC2 IGF2BP2 SYTL4 PHF3 MACF1 LAS1L SPEN EXOSC7	6.99e-07	724	215	18	36232890
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX HK2 GIGYF1 RCC2 PSME4 CASKIN2 BUB1B RALGDS NCAPD3 FRAS1 TCP1 EML4 SBNO2 ARAP3 TANC1 HPS5 AGRN	7.23e-07	650	215	17	38777146
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	KCNH7 PDGFRA ABCA12 NEK4 PAPOLA ADAMTS20 HERC2 NBPF14 FRAS1 TCP1 HNRNPA3 PIWIL4 ASXL3 SETBP1 TTC33	8.43e-07	513	215	15	25798074
Pubmed	Biology, structure and mechanism of P-type ATPases.	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.07e-07	29	215	5	15071553
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR2 RYR3	9.28e-07	4	215	3	23413940
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR2 RYR3	9.28e-07	4	215	3	9607712
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR2 RYR3	9.28e-07	4	215	3	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR2 RYR3	9.28e-07	4	215	3	18206662
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR2 RYR3	9.28e-07	4	215	3	9384575
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAP1A MDH2 CEP170 RPTOR CASKIN1 OSBPL8 CACNA1A FLNB FLNC FN1 TCP1 SYNE1 HNRNPA3 NPTN MTHFD1 MICAL2 VCAN MACF1 RIMBP2 TANC1 SSH2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 RPL13	9.64e-07	1431	215	26	37142655
Pubmed	Functional proteomics mapping of a human signaling pathway.	SYTL2 SVEP1 RYR2 PAPOLA RBM19 CHD6 HERC2 FLNB FLNC WASHC4 THSD7A FN1 BTBD2 OPTN KMT2D MACF1	9.90e-07	591	215	16	15231748
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	PDGFRA SSRP1 DDX10 CDCA2 RBM19 MKI67 FLNB FLNC RNF169 DDX31 NRAS TCP1 HNRNPA3 CAT EXOSC2 MTHFD1 PHF3 SUMO2 LAS1L EXOSC7 RPL13	1.03e-06	989	215	21	36424410
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	HK2 SSRP1 MDH2 A2ML1 C3 FLNB TCP1 CAT IDE CCDC7 MTHFD1 MACF1	1.06e-06	327	215	12	31409639
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	SSRP1 DDX10 CEP170 RBM19 MKI67 OSBPL8 SYNE1 TMEM43 EXOSC2 TMEM209 LAS1L EXOSC7	1.24e-06	332	215	12	25693804
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	HK2 MAP1A CEP170 BPNT1 AARS2 BSG FLNB EML4 LARS2 IGF2BP2 MTHFD1 TMEM209 LAS1L ATP2B1 SORD	1.39e-06	534	215	15	35032548
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SETX ARID4B SSRP1 DDX10 CDCA2 MKI67 SHPRH CHD6 HERC2 RNF169 DDX31 RFX5 EXOSC2 SBNO1 PHF3 SPEN	1.43e-06	608	215	16	36089195
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SETX SRM SSRP1 RCC2 CEP170 ATXN2 MKI67 NCAPD3 RARA TCP1 HNRNPA3 PPAT RFX5 CCDC7 IGF2BP2 KMT2D MTHFD1 SMARCA2 SUMO2 SPEN TTC33 SORD	1.58e-06	1103	215	22	34189442
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP1A ECD MDH2 RCC2 DDX10 CEP170 NEK1 PAPOLA BUB1B MKI67 PRMT7 TCP1 PUM2 USP16 IGF2BP2 MTHFD1 MACF1 CKAP2 RPL13 PCNT	1.67e-06	934	215	20	33916271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SNX13 PLEKHH1 CHD6 PLXNB3 FRAS1 SYNE1 PUM2 ARFGEF3 PHF3 MACF1 RIMBP2 SPEN PCNT	1.76e-06	407	215	13	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF331 CEP170 PLEKHH1 ATXN2 RPTOR SHPRH SEMA6A CHD6 WDR13 FLNB HNRNPA3 IDE SBNO2 HIVEP3 ARFGEF3 AOPEP MICAL2 SETBP1 SMARCA2 MACF1 ELK3 TANC1 CKAP2 HPS5 ATP2B1 PCNT	2.00e-06	1489	215	26	28611215
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HK2 TEX2 SSRP1 MDH2 AARS2 ATXN2 RPTOR VPS13A OSBPL8 HERC2 TCP1 SYNE1 HNRNPA3 PUM2 CAT IDE PPAT LARS2 MRPL39 ARFGEF3 IGF2BP2 TMEM209 TANC1 CKAP2 LAS1L PCNT	2.18e-06	1496	215	26	32877691
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR2 RYR3	2.31e-06	5	215	3	19011160
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR1 RYR2 RYR3	2.31e-06	5	215	3	23918386
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A GIGYF1 CEP170 BUB1B MKI67 RNF169 RFX5 KMT2D SPEN	2.39e-06	184	215	9	32908313
Pubmed	Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns.	SYTL2 GIGYF1 SSRP1 PCDH17 OSBPL8 CACNA1A	2.64e-06	63	215	6	17672918
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	MKI67 ADAMTS20 FN1 ADAMTS5 VCAN	2.78e-06	36	215	5	25615642
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HK2 PDGFRB SSRP1 MDH2 RCC2 DDX10 CDCA2 BSG RBM19 RPTOR MKI67 FLNB NCAPD3 TCP1 SYNE1 HNRNPA3 TMEM43 IDE PPAT SBNO1 MTHFD1 SPEN ATP2B1 ATP2B3 RPL13	2.94e-06	1425	215	25	30948266
Pubmed	Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.	MKI67 ADAMTS20 ADAMTS5 VCAN	3.17e-06	17	215	4	22183742
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MKRN2 SSRP1 MDH2 RCC2 DDX10 ATXN2 RBM19 FLNB DDX31 TCP1 SYNE1 HNRNPA3 PUM2 IGF2BP2 MACF1 SUMO2 LAS1L SPEN	3.21e-06	807	215	18	22681889
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TEX2 SYNE1 ASXL3 CNTNAP4 TANC1 FHDC1 SSH2	3.51e-06	102	215	7	11214970
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	MAP1A MYO9B MDH2 RYR1 CFB CEP170 A2ML1 C3 PLCD1 TCP1 HNRNPA3 CAT IDE SUMO2 CKAP2 EXOSC7 PCNT	3.58e-06	732	215	17	34732716
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PLEKHH1 AARS2 PLXNB3 SYNE1 ADAMTSL3 ARFGEF3 MACF1	3.75e-06	103	215	7	10574462
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	BUB1B MLLT3 RNF169 FN1 CAT KMT2D TANC1	4.54e-06	106	215	7	31024071
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	19549818
Pubmed	Characterization of PISP, a novel single-PDZ protein that binds to all plasma membrane Ca2+-ATPase b-splice variants.	ATP2B1 ATP2B2 ATP2B4	4.60e-06	6	215	3	12763866
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	25966694
Pubmed	Vector-capping: a simple method for preparing a high-quality full-length cDNA library.	FLNB FN1 AGRN	4.60e-06	6	215	3	16106752
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	20519450
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	26025922
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	23463619
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	14592808
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	19009018
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 RYR2 RYR3	4.60e-06	6	215	3	16844763
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYO9B RYR1 EHBP1L1 PSME4 RBM19 RPTOR CASKIN1 HERC2 FLNC FRAS1 LARS2 SBNO2 HIVEP3 KMT2D ARAP3 CTDP1 PCNX1 TANC1 SPEN AGRN PCNT	5.79e-06	1105	215	21	35748872
Interaction	C17orf78 interactions	NPTN ATP2B1 ATP2B2 ATP2B3 ATP2B4	9.17e-08	12	212	5	int:C17orf78
Interaction	HSD17B6 interactions	ATP12A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.39e-07	15	212	5	int:HSD17B6
Interaction	MAPRE3 interactions	MAP1A MYO9B FCHO1 KIF24 CEP170 NEK4 NEK1 EML4 MACF1 TANC1 CKAP2 PCNT	6.18e-06	230	212	12	int:MAPRE3
Interaction	PTEN interactions	SETX PDGFRA PDGFRB SSRP1 RCC2 CFB RYR3 CEP170 RPTOR MKI67 FLNB FN1 TCP1 HNRNPA3 CAT IDE EXOSC2 CCDC7 ARAP3 MTHFD1 CAPRIN2 EXOSC7 ATP2B1 AGRN RPL13	1.63e-05	929	212	25	int:PTEN
Interaction	AKAP6 interactions	RYR1 RYR2 OPTN PCNT	2.54e-05	17	212	4	int:AKAP6
GeneFamily	ATPases Ca2+ transporting	ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.71e-07	9	144	4	1209
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2 RYR3	4.95e-07	3	144	3	287
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	SYTL2 RYR1 CDCA2 MKI67 DDX31 ARFGEF3 RIMBP2	6.23e-04	181	144	7	694
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SETX MYO9B SNX13 DDX10 CEP170 NEK4 NEK1 PSME4 ATXN2 BUB1B VPS13A OSBPL8 NBPF14 FLNB WASHC4 PUM2 INPP5F LARS2 MICAL2 PHF3 SMARCA2 MACF1 SPEN ATP2B1 ATP2B4 PCNT	9.39e-09	856	214	26	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ZBTB38 SYTL2 SLC24A3 PDZD7 GIGYF1 PCDH17 RYR2 CASKIN1 MLLT3 CACNA1A RALGDS THSD7A HIVEP3 ARFGEF3 OPTN RGS6 ASXL3 VCAN CAPRIN2 FAM217B CNTNAP4 B3GAT1 RIMBP2 SSH2 NRSN1 TOX2 ATP2B1 ATP2B2	1.15e-07	1106	214	28	M39071
Coexpression	SCHUHMACHER_MYC_TARGETS_UP	SRM DDX10 PPAT EXOSC2 MTHFD1 EXOSC7 SORD	4.20e-06	80	214	7	M12243
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ZBTB38 SETX ARID4B MYO9B ZNF831 NXPE3 PAPOLA OSBPL8 RALGDS TCP1 EML4 SYNE1 HNRNPA3 PUM2 TMEM43 RFX5 CARD8 SBNO2 HIVEP3 KMT2D SBNO1 PHF3 SMARCA2 MACF1 PCNX1 SSH2 CKAP2 SPEN ATP2B4 RPL13	4.76e-06	1492	214	30	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SNX13 CEP170 ATXN2 BUB1B VPS13A OSBPL8 FLNB WASHC4 PUM2 INPP5F LARS2 PHF3 SMARCA2 SPEN ATP2B1	7.45e-06	466	214	15	M13522
Coexpression	GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP	PDGFRB MDH2 HS3ST3B1 HS3ST3A1 FLNB EML4 ALPK1 VCAN TANC1	1.21e-05	171	214	9	M8594
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	PSME4 MLLT3 HERC2 SYNE1 USP16 SBNO1 MACF1 TANC1 HPS5	2.17e-05	184	214	9	M9005
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	ZBTB38 HK2 SYTL2 RCC2 PAPOLA BUB1B OSBPL8 NBPF14 NRAS WASHC4 FN1 USP16 IGF2BP2 MICAL2 VCAN CKAP2 TOX2 ATP2B1	2.88e-05	721	214	18	M10237
Coexpression	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN	NEK1 PAPOLA PLCD1 RNF169 TCP1 EXOSC2 MTHFD1 PCNX1 SORD	4.17e-05	200	214	9	M5078
Coexpression	JOHNSTONE_PARVB_TARGETS_3_UP	C3 NBPF14 FLNB FRAS1 FN1 CAT TMEM43 OPTN MICAL2 TANC1 TOX2 AGRN ATP2B4	6.22e-05	433	214	13	M2240
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	ZBTB38 SYTL2 SLC24A3 PDZD7 PCDH17 RYR2 ZNF283 CACNA1A RALGDS ADAMTS5 ARFGEF3 OPTN ASXL3 RIMBP2 TOX2 ATP2B1 ATP2B2	7.14e-05	703	214	17	M39070
Coexpression	STARK_HYPPOCAMPUS_22Q11_DELETION_UP	RCC2 PAPOLA AOPEP PCNX1 B3GAT1	7.22e-05	53	214	5	MM582
Coexpression	STARK_HYPPOCAMPUS_22Q11_DELETION_UP	RCC2 PAPOLA AOPEP PCNX1 B3GAT1	7.91e-05	54	214	5	M12050
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	SETX MYO9B SLC24A3 MDH2 DDX10 ZNF331 CDCA2 SEMA6A CHD6 HERC2 HNRNPA3 LARS2 EXOSC2 IGF2BP2 AOPEP SETBP1 SMARCA2 FAM217B SUMO2 SSH2 EXOSC7	8.71e-05	1009	214	21	M157
Coexpression	DESCARTES_ORGANOGENESIS_MYOCYTES	SYTL2 SLC24A3 RYR1 CHRND FLNC CAPN6 C4orf54	9.44e-05	129	214	7	MM3644
Coexpression	TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL	CEP170 EHBP1L1 FMN1 USP32 HS3ST3B1 NBPF14 RALGDS RARA SLC36A4 EML4 HNRNPA3 SBNO2 HIVEP3 VCAN PCNX1 ELK3 ATP2B1	1.02e-04	724	214	17	M41700
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	SETX PCDH17 RYR2 SNX13 NEK1 SHPRH HERC2 RELCH IDE SBNO1 PHF3 ASXL3 VCAN ATP2B1 AGRN TGS1	2.30e-07	330	212	16	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	SETX PCDH17 RYR2 RYR3 SNX13 NXPE3 CEP170 NEK1 SHPRH ADAMTS20 MLLT3 HERC2 RELCH IDE ADAMTS5 SBNO1 SYTL4 PHF3 ASXL3 VCAN CNTNAP4 NRSN1 ATP2B1 AGRN TGS1	7.06e-07	818	212	25	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	SETX PDGFRB PCDH17 RYR2 NEK1 RPTOR SHPRH HERC2 RELCH PUM2 IDE SBNO1 PHF3 ASXL3 VCAN AGRN	1.77e-06	385	212	16	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	PDGFRA SLC24A3 PCDH17 RYR3 SNX13 NXPE3 CDCA2 NEK1 EHBP1L1 PAPOLA VPS13A SHPRH OSBPL8 ADAMTS20 RELCH WASHC4 SYNE1 MANEA ITIH5 VCAN ATP2B1 AGRN ATP2B4	3.11e-06	772	212	23	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	MAP1A PDGFRA PDGFRB SYTL2 SVEP1 HS3ST3A1 FLNC CAPN6 MICAL2 ASXL3 VCAN	7.86e-06	207	212	11	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	PDGFRA PDGFRB SVEP1 FLNC FN1 ADAMTS5 ITIH5 MICAL2 VCAN ATP2B4	1.53e-05	182	212	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ARID4B MAP1A DDX10 NEK4 NEK1 VPS13A MKI67 MLLT3 CACNA1A WASHC4 THSD7A HNRNPA3 MANEA CAT PPAT LARS2 ZNF786 SETBP1 B3GAT1 TOX2 ATP2B1 ATP2B2 PHTF1 PCNT TGS1	1.95e-05	989	212	25	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	SETX TEX2 KIF24 RCC2 DDX10 CDCA2 BPNT1 SYCP2 FMN1 BUB1B PRMT7 NCAPD3 RELCH FN1 TCP1 PIWIL4 IDE OPTN SBNO1 CAPRIN2 RIMBP2 CKAP2	2.17e-05	810	212	22	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	PDGFRA PDGFRB CFB DES C3 FN1 ITIH5	2.47e-05	86	212	7	GSM777055_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	SETX PDGFRB PCDH17 RYR2 RYR3 NEK1 RPTOR SHPRH MAP3K10 ADAMTS20 HERC2 RELCH THSD7A PUM2 IDE SBNO1 PHF3 ASXL3 VCAN CNTNAP4 NRSN1 AGRN	2.52e-05	818	212	22	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	SETX PDGFRA PCDH17 SNX13 NEK4 HERC2 RELCH PHF3 VCAN AGRN	2.66e-05	194	212	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1A PDGFRA PDGFRB SYTL2 SVEP1 HS3ST3A1 FLNC CAPN6 MICAL2 ASXL3 VCAN ATP2B4 TGS1	3.66e-05	337	212	13	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500	SLC24A3 PCDH17 RYR3 NXPE3 CDCA2 EHBP1L1 VPS13A ADAMTS20 RELCH WASHC4 SYNE1 VCAN ATP2B1 AGRN	4.38e-05	393	212	14	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	PDGFRA PDGFRB FN1 ADAMTS5 ITIH5 MICAL2 VCAN ATP2B4	4.95e-05	130	212	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	PDGFRA PDGFRB SYTL2 SLC24A3 SVEP1 HS3ST3A1 FLNC FRAS1 CAPN6 ASXL3 VCAN SMARCA2 TGS1	6.05e-05	354	212	13	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	SETX PDGFRA PCDH17 SNX13 NEK4 VPS13A SHPRH HERC2 RELCH IDE PHF3 VCAN AGRN	9.20e-05	369	212	13	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	PDGFRA PDGFRB HS3ST3A1 FLNC ADAMTS5 ITIH5 VCAN ATP2B4	1.18e-04	147	212	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500	PDGFRA PDGFRB SLC24A3 RYR2 HS3ST3A1 FLNC TCP1 CAPN6 ALPK1 IGF2BP2 ASXL3 VCAN ATP2B3	1.51e-04	388	212	13	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200	PDGFRA PDGFRB ADAMTS5 ITIH5 VCAN ATP2B4	1.72e-04	82	212	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	SETX TEX2 RCC2 DDX10 BPNT1 PRMT7 NCAPD3 TCP1 IDE POLG2	1.74e-04	243	212	10	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500	PDGFRA PDGFRB SVEP1 ADAMTS5 ITIH5 MICAL2 VCAN ATP2B4	1.77e-04	156	212	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	SETX PDGFRA PCDH17 RYR2 RPTOR SHPRH HERC2 PUM2 PHF3 VCAN ATP2B1 AGRN TGS1	1.89e-04	397	212	13	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	PDGFRA SVEP1 CFB DES C3 FN1	2.38e-04	87	212	6	GSM777050_100
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	SETX TEX2 SRM RCC2 CDCA2 BPNT1 BUB1B PRMT7 NCAPD3 TCP1 IDE PPAT MTHFD1 CKAP2	2.45e-04	463	212	14	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	HK2 MAP1A PDGFRA PDGFRB SYTL2 SVEP1 BUB1B SEMA6A HS3ST3A1 FLNC TCP1 CAPN6 IGF2BP2 MICAL2 ASXL3 VCAN ATP2B1 ATP2B3 ATP2B4 TGS1	2.47e-04	827	212	20	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	PDGFRA PDGFRB SVEP1 HS3ST3A1 FLNC FN1 ADAMTS5 ALPK1 ITIH5 MICAL2 VCAN ATP2B4	2.57e-04	356	212	12	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	PDGFRA PDGFRB FLNC CAPN6 ITIH5 MICAL2 VCAN ATP2B4	2.60e-04	165	212	8	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	PDGFRA PDGFRB SVEP1 FLNC CAPN6 ADAMTS5 ITIH5 MICAL2 ASXL3 VCAN ATP2B4	3.00e-04	310	212	11	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200	PDGFRA PDGFRB MICAL2 VCAN ATP2B4	3.06e-04	59	212	5	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000	PDGFRA PDGFRB SVEP1 FN1 CAPN6 ASXL3 VCAN SETBP1 CNTNAP4 POLG2	3.08e-04	261	212	10	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	MAP1A PDGFRA PDGFRB SYTL2 SLC24A3 SVEP1 MKI67 HS3ST3A1 FLNC FRAS1 FN1 ADAMTS5 ITIH5 IGF2BP2 MICAL2 ASXL3 VCAN CKAP2 ATP2B4	3.09e-04	777	212	19	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	HK2 MAP1A PDGFRA PDGFRB SYTL2 SVEP1 HS3ST3A1 FLNC CAPN6 IGF2BP2 MICAL2 ASXL3 VCAN	3.11e-04	418	212	13	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	HK2 PDGFRA PDGFRB HS3ST3A1 FLNC CAPN6 ALPK1 ITIH5 IGF2BP2 MICAL2 VCAN ATP2B4	3.14e-04	364	212	12	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100	PCDH17 RYR2 VCAN AGRN	3.15e-04	33	212	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000	SETX TEX2 SRM RCC2 DDX10 CDCA2 BPNT1 SYCP2 BUB1B PRMT7 NCAPD3 TCP1 IDE PPAT MTHFD1 CAPRIN2 CKAP2 NRSN1 RPL13	3.29e-04	781	212	19	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ARID4B SSRP1 CEP170 PLEKHH1 NEK1 USP32 MKI67 HNRNPA3 CAT INPP5F LARS2 MICAL2 MACF1 B3GAT1 CKAP2 POLG2	3.33e-04	595	212	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	PDGFRA PDGFRB SLC24A3 SVEP1 FLNC CAPN6 ITIH5 ASXL3 VCAN ATP2B4	3.47e-04	265	212	10	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	SETX TEX2 RCC2 DDX10 CDCA2 BPNT1 SYCP2 BUB1B PRMT7 NCAPD3 TCP1 IDE PPAT OPTN MTHFD1 CAPRIN2 RIMBP2 CKAP2 RPL13	4.10e-04	795	212	19	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	PDGFRA PDGFRB CFB DES C3 ITIH5	4.29e-04	97	212	6	GSM777043_100
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000	PDGFRA PDGFRB DBH SVEP1 RYR2 RYR3 FN1 CAPN6 ADAMTS5 ARFGEF3 SYTL4 ASXL3 VCAN SETBP1 CNTNAP4 NRSN1 POLG2 RPL13	4.31e-04	734	212	18	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	PDGFRA PDGFRB SLC24A3 SVEP1 RYR2 HS3ST3A1 FLNC TCP1 CAPN6 ALPK1 ITIH5 IGF2BP2 SYTL4 ASXL3 VCAN CAPRIN2 ATP2B3 ATP2B4	4.74e-04	740	212	18	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200	PDGFRA PDGFRB HS3ST3A1 ALPK1 MICAL2 VCAN ATP2B4	4.81e-04	138	212	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	PDGFRA PDGFRB SYTL2 SLC24A3 SVEP1 FLNC ADAMTS5 ITIH5 MICAL2 VCAN ATP2B4	5.89e-04	336	212	11	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	SETX TEX2 KIF24 DDX10 BPNT1 NEK1 SYCP2 USP32 VPS13A PRMT7 NCAPD3 RELCH TCP1 IDE CAPRIN2 TMEM209 SSH2 CKAP2 PHTF1	5.97e-04	820	212	19	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	PCDH17 RYR2 RPTOR VCAN AGRN	6.33e-04	69	212	5	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200	PDGFRA PDGFRB HS3ST3A1 ADAMTS5 ITIH5 VCAN ATP2B4	6.73e-04	146	212	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500	PDGFRA PDGFRB SLC24A3 FLNC CAPN6 ASXL3 VCAN	6.73e-04	146	212	7	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	PDGFRA PDGFRB SYTL2 SLC24A3 SVEP1 SEMA6A HS3ST3A1 FLNC FRAS1 TCP1 CAPN6 ALPK1 IGF2BP2 ASXL3 VCAN SMARCA2 ATP2B1 ATP2B3 TGS1	7.00e-04	831	212	19	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	HK2 PDGFRA PDGFRB SVEP1 HS3ST3A1 FLNC TCP1 CAPN6 ADAMTS5 ALPK1 ITIH5 IGF2BP2 MICAL2 ASXL3 VCAN ATP2B4 SLC6A14 TGS1	7.29e-04	768	212	18	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200	PDGFRA HS3ST3A1 MICAL2 VCAN	8.03e-04	42	212	4	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	SETX PDGFRA PCDH17 RYR3 SNX13 NEK4 HERC2 RELCH PHF3 VCAN CNTNAP4 AGRN	8.61e-04	408	212	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	SYTL2 ZNF831 RYR2 OSBPL8 EML4 SMARCA2 PCNX1 ELK3 TOX2 ATP2B4 PHTF1	3.10e-09	195	215	11	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B SYTL2 VPS13A MLLT3 PARP15 FRAS1 THSD7A EML4 SYNE1 SMARCA2 MACF1	3.45e-09	197	215	11	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RYR2 RYR3 SYCP2 ADAMTS20 FRAS1 ARFGEF3 ASXL3 CNTNAP4 MYO15A	2.34e-08	184	215	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RYR2 RYR3 SYCP2 ADAMTS20 FRAS1 ARFGEF3 ASXL3 CNTNAP4 MYO15A	2.34e-08	184	215	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RYR2 RYR3 SYCP2 ADAMTS20 FRAS1 ARFGEF3 ASXL3 CNTNAP4 MYO15A	2.34e-08	184	215	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA PDGFRB SVEP1 CFB C3 FN1 ADAMTS5 ADAMTSL3 ITIH5	2.59e-08	186	215	10	a7ab70b049742dfe7ee30557031bfac6412edf52
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCNH7 PCDH17 SEMA6A PARP15 ITIH5 IGF2BP2 RGS6 P2RX7 ELK3 TOX2	2.72e-08	187	215	10	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH17 CASKIN2 SEMA6A FRAS1 ITIH5 IGF2BP2 RGS6 P2RX7 TANC1 TOX2	3.49e-08	192	215	10	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	PDGFRA SVEP1 RYR2 FRAS1 FN1 ITIH5 IGF2BP2 SETBP1 TANC1 TOX2	4.04e-08	195	215	10	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH7 RYR2 OSBPL8 NPTN SETBP1 RIMBP2 ATP2B1 ATP2B2 CDH18 PHTF1	4.67e-08	198	215	10	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA PDGFRB SYTL2 SVEP1 RYR2 FN1 SYNE1 SYTL4 VCAN MACF1	4.90e-08	199	215	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	ZNF273 NXPE3 RBM19 VPS13A MKI67 CACNA1A CKAP2 POLG2 JRKL PCNT	5.13e-08	200	215	10	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	RYR2 CACNA1A SYNE1 NPTN MICAL2 SETBP1 RIMBP2 ATP2B1 ATP2B2 CDH18	5.13e-08	200	215	10	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZBTB38 SETX PCDH17 CASKIN2 ITIH5 IGF2BP2 SMARCA2 ELK3 ARHGAP27 TOX2	5.13e-08	200	215	10	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	PDGFRB SYTL2 SVEP1 FN1 SYNE1 ITIH5 SYTL4 VCAN MACF1 ATP2B1	5.13e-08	200	215	10	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 SVEP1 RYR2 RYR3 FRAS1 CCDC7 CNTNAP4 RIMBP2 ABCC12	8.87e-08	160	215	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 SVEP1 RYR2 RYR3 FRAS1 CCDC7 CNTNAP4 RIMBP2 ABCC12	8.87e-08	160	215	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RYR2 RYR3 MYO3B FRAS1 LARS2 ATP12A ATP2B2 RPL13	1.42e-07	169	215	9	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA PDGFRB SVEP1 HS3ST3A1 FN1 CAPN6 ADAMTSL3 ITIH5 VCAN	2.66e-07	182	215	9	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 KIF24 SVEP1 CDCA2 BUB1B MKI67 FN1 IHO1 CKAP2	3.34e-07	187	215	9	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 KIF24 SVEP1 CDCA2 BUB1B MKI67 FN1 IHO1 CKAP2	3.34e-07	187	215	9	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA SYTL2 DES FLNC FN1 ADAMTS5 ITIH5 RPL13	3.49e-07	188	215	9	7191087d8754f5e8700e3d744cd920ee26db1e57
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH17 ZNF331 CASKIN2 SEMA6A ITIH5 RGS6 P2RX7 ELK3 TOX2	3.49e-07	188	215	9	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH17 CASKIN2 SEMA6A FRAS1 IGF2BP2 RGS6 P2RX7 TANC1 TOX2	3.82e-07	190	215	9	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PCDH17 ZNF331 CASKIN2 SEMA6A SYNE1 ARAP3 RGS6 TANC1 TOX2	3.82e-07	190	215	9	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 FMN1 MYO3B MLLT3 FRAS1 RGS6 ASXL3 SETBP1 RIMBP2	3.82e-07	190	215	9	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	RYR2 ZNF331 PSME4 HS3ST3A1 FLNC AOPEP TANC1 ATP2B4 MYBPC3	3.82e-07	190	215	9	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PCDH17 ZNF331 CASKIN2 SEMA6A SYNE1 ARAP3 RGS6 TANC1 TOX2	3.82e-07	190	215	9	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA SYTL2 DES C3 THSD7A ADAMTS5 ITIH5 VCAN	3.99e-07	191	215	9	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PCDH17 ZNF331 CASKIN2 SEMA6A SYNE1 ARAP3 RGS6 TANC1 TOX2	3.99e-07	191	215	9	f229abf69a1217194f74b0502486907e07dba989
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B ATXN2 CHD6 ACSS3 FRAS1 EML4 IGF2BP2 PHF3 VCAN	4.17e-07	192	215	9	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB SVEP1 C3 FN1 ADAMTS5 ITIH5 NPTN VCAN	4.17e-07	192	215	9	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA SRM SVEP1 C3 FN1 ADAMTS5 ITIH5 VCAN	4.17e-07	192	215	9	2d9e2262f1342fe17735f21f733c029d1275e955
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	SLC24A3 SVEP1 RYR2 OSBPL8 FRAS1 FN1 HIVEP3 MACF1 TANC1	4.17e-07	192	215	9	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH17 CASKIN2 SEMA6A ITIH5 IGF2BP2 P2RX7 TANC1 TOX2 ATP2B4	4.36e-07	193	215	9	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B ATXN2 CHD6 ACSS3 FRAS1 EML4 IGF2BP2 PHF3 VCAN	4.36e-07	193	215	9	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA SRM SVEP1 C3 FN1 ADAMTS5 ITIH5 VCAN	4.36e-07	193	215	9	45b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYTL2 VPS13A PARP15 RELCH FRAS1 THSD7A EML4 SYNE1 MACF1	4.36e-07	193	215	9	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	facs-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB SVEP1 DES C3 ADAMTS5 ADAMTSL3 ITIH5 VCAN	4.55e-07	194	215	9	fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB SVEP1 DES C3 ADAMTS5 ADAMTSL3 ITIH5 VCAN	4.55e-07	194	215	9	bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYTL2 C3 FLNB FLNC FN1 ADAMTS5 ADAMTSL3 ITIH5 VCAN	4.55e-07	194	215	9	7b6ec45adb7ece3c8a7b78c5782413b5825effe2
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB SVEP1 DES C3 ADAMTS5 ADAMTSL3 ITIH5 VCAN	4.55e-07	194	215	9	6afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR2 SYNE1 NPTN MICAL2 SETBP1 RIMBP2 ATP2B1 ATP2B2 CDH18	4.96e-07	196	215	9	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	IPF-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	ZNF831 RYR2 OSBPL8 EML4 SMARCA2 PCNX1 ELK3 ATP2B4 PHTF1	4.96e-07	196	215	9	6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ZBTB38 SYTL2 ZNF831 PARP15 SYNE1 OPTN MACF1 B3GAT1 ATP2B4	5.17e-07	197	215	9	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SETX PDGFRB PDZD7 SYNE1 SETBP1 SMARCA2 MACF1 TANC1 ATP2B4	5.40e-07	198	215	9	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR2 CACNA1A SYNE1 NPTN MICAL2 SETBP1 ATP2B1 ATP2B2 CDH18	5.40e-07	198	215	9	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR2 CACNA1A SYNE1 NPTN MICAL2 SETBP1 ATP2B1 ATP2B2 CDH18	5.40e-07	198	215	9	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR2 CACNA1A SYNE1 NPTN MICAL2 SETBP1 ATP2B1 ATP2B2 CDH18	5.40e-07	198	215	9	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFRB SYTL2 RYR2 DES EHBP1L1 FLNC FN1 RGS6 SETBP1	5.63e-07	199	215	9	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFRA PDGFRB SVEP1 FN1 SYNE1 ALPK1 SYTL4 VCAN MACF1	5.87e-07	200	215	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SETX CASKIN2 PARP15 ITIH5 IGF2BP2 OPTN ELK3 TANC1 TOX2	5.87e-07	200	215	9	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX PCDH17 CASKIN2 ITIH5 IGF2BP2 MACF1 ELK3 TANC1 TOX2	5.87e-07	200	215	9	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX PCDH17 CASKIN2 ITIH5 IGF2BP2 ELK3 TANC1 ARHGAP27 TOX2	5.87e-07	200	215	9	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFRB SVEP1 C3 HS3ST3A1 ACSS3 FN1 SYNE1 ADAMTSL3 VCAN	5.87e-07	200	215	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX PCDH17 CASKIN2 FLNB ITIH5 IGF2BP2 ARAP3 ELK3 TOX2	5.87e-07	200	215	9	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	PDGFRA PDGFRB SVEP1 RYR2 ALPK1 ITIH5 SYTL4 VCAN MACF1	5.87e-07	200	215	9	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX PCDH17 CASKIN2 FLNB ITIH5 IGF2BP2 ARAP3 ELK3 TOX2	5.87e-07	200	215	9	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFRB SVEP1 RYR2 FRAS1 FN1 ADAMTSL3 ITIH5 SETBP1 TOX2	5.87e-07	200	215	9	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA PDGFRB SVEP1 C3 FN1 ADAMTS5 ADAMTSL3 ITIH5 VCAN	5.87e-07	200	215	9	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	PDGFRB SYTL2 RYR2 DES HS3ST3A1 SYNE1 ADAMTS5 ADAMTSL3 VCAN	5.87e-07	200	215	9	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA PDGFRB SVEP1 C3 FN1 ADAMTS5 ADAMTSL3 ITIH5 VCAN	5.87e-07	200	215	9	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA2 MKI67 C3 NCAPD3 MOGAT2 SYNE1 SLC10A5 NRSN1	1.38e-06	164	215	8	2a230ea066decb798a0e6f2b96c7608c8e608031
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA2 MKI67 C3 NCAPD3 MOGAT2 SYNE1 SLC10A5 NRSN1	1.38e-06	164	215	8	d02d39edd0bfef5a53b814ec6d5f026d41253218
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCDH17 CDCA2 BUB1B MKI67 NCAPD3 ARAP3 CKAP2 TOX2	1.58e-06	167	215	8	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	PDGFRA SVEP1 CFB C3 SRR ADAMTS5 LAS1L RPL13	1.72e-06	169	215	8	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 RYR3 MYO3B C3 FLNC LARS2 ATP12A RPL13	2.05e-06	173	215	8	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR2 RYR3 MYO3B C3 FLNC LARS2 ATP12A RPL13	2.05e-06	173	215	8	649b08a409095592cccf31883be69c754411280d
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA DES C3 FLNC ADAMTS5 ITIH5 RPL13	2.14e-06	174	215	8	68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 DES FLNC SBNO2 RIMBP2 ATP12A ATP2B2 RPL13	2.14e-06	174	215	8	f230d23618a6487f2664efb2c677e0a4559e2bf4
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	MAP1A HS3ST3A1 LETM2 THSD7A ITIH5 SYTL4 VCAN ATP2B1	2.54e-06	178	215	8	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	facs-Kidney-nan-24m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRB SVEP1 DES C3 FLNC FN1 ADAMTS5 ITIH5	2.76e-06	180	215	8	f9f8245cbcdea18c15e2976c85b72c6807309787
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM18 BUB1B NCAPD3 CAPN6 PIWIL4 SYTL4 FAM217B CKAP2	2.87e-06	181	215	8	b203b616584cdbd0bbb0e382b2916d0bd49d3526
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM18 BUB1B NCAPD3 CAPN6 PIWIL4 SYTL4 FAM217B CKAP2	2.87e-06	181	215	8	c748c16fd20d1949d33ff6290dc9d9016c4dc86c
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA2 BUB1B MKI67 C3 NCAPD3 MOGAT2 SYNE1 OPTN	2.87e-06	181	215	8	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA2 BUB1B MKI67 C3 NCAPD3 MOGAT2 SYNE1 OPTN	2.87e-06	181	215	8	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF273 NXPE3 VPS13A MKI67 CACNA1A CKAP2 JRKL PCNT	3.24e-06	184	215	8	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF273 NXPE3 VPS13A MKI67 CACNA1A CKAP2 JRKL PCNT	3.24e-06	184	215	8	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF273 NXPE3 VPS13A MKI67 CACNA1A CKAP2 JRKL PCNT	3.24e-06	184	215	8	d31d4116d1d196633784863781fa45673607a421
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	ZNF273 NXPE3 VPS13A MKI67 CACNA1A POLG2 JRKL PCNT	3.24e-06	184	215	8	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF273 NXPE3 VPS13A MKI67 CACNA1A CKAP2 JRKL PCNT	3.24e-06	184	215	8	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	ZNF273 NXPE3 VPS13A MKI67 CACNA1A CKAP2 JRKL PCNT	3.24e-06	184	215	8	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	ZNF273 NXPE3 VPS13A MKI67 CACNA1A POLG2 JRKL PCNT	3.24e-06	184	215	8	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO9B RYR3 DES FLNC AOPEP MICAL2 VCAN ELK3	3.38e-06	185	215	8	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA SVEP1 CFB C3 FN1 ADAMTS5 ADAMTSL3	3.52e-06	186	215	8	ff6ccfdf2509f96caa10281c29a95b432f6c6dcc
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	PDGFRA SVEP1 RYR2 HS3ST3A1 FN1 ADAMTSL3 ITIH5 SETBP1	3.66e-06	187	215	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	PDGFRA SVEP1 RYR2 FRAS1 FN1 ADAMTSL3 SETBP1 MACF1	3.66e-06	187	215	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SYTL2 SLC24A3 RYR2 RYR3 FLNB FN1 MICAL2 MACF1	3.80e-06	188	215	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDGFRB SYTL2 RYR2 DES HS3ST3A1 SYNE1 ADAMTS5 ADAMTSL3	3.96e-06	189	215	8	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRA SRM SLC24A3 ADAMTS20 ADAMTSL3 VCAN CNTNAP4 TOX2	3.96e-06	189	215	8	979b7fa947538aa7ca4a219263da2575869a2caa
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	RYR2 ZNF331 PSME4 FLNC AOPEP TANC1 ATP2B4 MYBPC3	3.96e-06	189	215	8	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA C3 FLNC FN1 ADAMTS5 ITIH5 VCAN	3.96e-06	189	215	8	0a8b827bba1efd885ad6c06929251c741dc3a541
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA PDGFRB SVEP1 FN1 ADAMTS5 ITIH5 VCAN	4.11e-06	190	215	8	bd0d68dc1b6f388190a6ba8a83b011619abe2bdd
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA PDGFRB SVEP1 FN1 ADAMTS5 ITIH5 VCAN	4.11e-06	190	215	8	e275de94468872e70cf305b3b450823d4c9c5e3f
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PDGFRA PDGFRB SVEP1 FN1 ADAMTS5 ITIH5 VCAN	4.11e-06	190	215	8	ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH17 CASKIN2 SEMA6A ITIH5 ARAP3 RGS6 ARHGAP27 TOX2	4.11e-06	190	215	8	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB ADAM18 SLC24A3 SVEP1 ADAMTS5 ADAMTSL3 ITIH5	4.11e-06	190	215	8	f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA PDGFRB SVEP1 THSD7A ADAMTS5 ADAMTSL3 ITIH5 VCAN	4.28e-06	191	215	8	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB38 SYTL2 ZNF831 VPS13A EML4 SYNE1 OPTN ATP2B4	4.28e-06	191	215	8	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYTL2 C3 FLNB FLNC FN1 ADAMTS5 ITIH5 VCAN	4.44e-06	192	215	8	30cefa0990ba1f379f350bfbf994a78db145075e
Drug	mag-fura-2	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.18e-08	37	210	7	CID000123839
Drug	C13932	RYR1 RYR2 RYR3 CACNA1A RARA FN1 CAT B3GAT1 HPS5 ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.64e-08	206	210	13	CID000168297
Drug	strontium	RYR1 RYR2 RYR3 P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.11e-07	68	210	8	CID000104798
Drug	KB-R7943	SLC24A3 RYR1 RYR3 RBM19 SYNE1 ATP2B1 ATP2B2	2.36e-07	47	210	7	CID004534086
Drug	acetyl phosphate	VPS13A ACSS3 CAT LARS2 MTHFD1 ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.15e-07	98	210	9	CID000000186
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A	MAP1A SVEP1 RYR1 RYR2 UBA7 HS3ST3A1 FGFBP1 FN1 SBNO2 CTDP1 ELK3 ATP2B4	3.33e-07	198	210	12	2811_UP
Drug	AC1L1IZE	DBH RYR1 RYR2 RYR3 SRR P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.93e-07	131	210	10	CID000004799
Drug	cis-diammineplatinum(II	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID002750949
Drug	8N3-cADPR	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID000127713
Drug	aminodantrolene	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID000093551
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2 RYR3	7.74e-07	3	210	3	CID005748312
Drug	1sqc	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.41e-06	10	210	4	CID000444279
Drug	Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	SETX SNX13 PAPOLA C3 SEMA6A ALPK1 HIVEP3 SBNO1 ELK3 AGBL2 TTC33	1.90e-06	193	210	11	3251_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	ZNF273 MDH2 NEK1 PSME4 CASKIN2 PRMT7 RALGDS MANEA SBNO2 SMARCA2 ATP2B4	2.10e-06	195	210	11	7444_DN
Drug	oxalate	DBH MDH2 RYR1 RYR2 RYR3 CAT ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.20e-06	158	210	10	CID000000971
Drug	AC1MMLID	SLC24A3 RYR1 RYR2 HPS5 ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.20e-06	92	210	8	CID000013245
Drug	2,5-dimethylquinone	ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.21e-06	11	210	4	CID000008718
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	EHBP1L1 RBM19 VPS13A PLCD1 FN1 BTBD2 EXOSC2 HIVEP3 MICAL2 ELK3 ATP2B4	2.32e-06	197	210	11	6801_UP
Drug	chlordecone	C3 CAT ATP2B1 ATP2B2 ATP2B3 ATP2B4 SORD	2.80e-06	67	210	7	CID000000299
Drug	Gg P	MDH2 RYR1 CFB CARD8 B3GAT1	2.91e-06	25	210	5	CID005288387
Drug	PCB74	RYR1 RYR2 RYR3	3.07e-06	4	210	3	CID000036218
Drug	148504-47-6	RYR1 RYR2 RYR3	3.07e-06	4	210	3	CID006444275
Drug	SC 38249	RYR1 RYR2 RYR3	3.07e-06	4	210	3	CID000134834
Drug	AC1L1U7A	RYR1 RYR2 RYR3	3.07e-06	4	210	3	CID000035682
Drug	1vyq	ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.29e-06	12	210	4	CID004369390
Drug	Ro 46861	ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.29e-06	12	210	4	CID000003128
Drug	Ryanodine	RYR1 RYR2 RYR3 CAT	3.29e-06	12	210	4	ctd:D012433
Drug	tBuBHQ	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.41e-06	69	210	7	CID000002374
Drug	indo-1	RCC2 RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.82e-06	99	210	8	CID000105060
Drug	8-hydroxycoumarin	ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.71e-06	13	210	4	CID000122783
Drug	p-hydroxyhippuric acid	ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.55e-06	14	210	4	CID000151012
Drug	Bay K 8644	RYR1 RYR2 RYR3 RBM19 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.10e-05	150	210	9	CID000002303
Drug	3-(1H-pyrrole-2-carboxylate	SLC24A3 RCC2 RYR1 RYR2 RYR3 CACNA1A TMEM43 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.15e-05	233	210	11	CID000005114
Drug	XeC compound	RYR1 RYR2 RYR3 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.28e-05	84	210	7	CID000005701
Drug	AC1NSKPI	IDE P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.41e-05	57	210	6	CID005311482
Drug	manganese	MDH2 RYR1 CFB RYR2 RYR3 CHRND PAPOLA CACNA1A FN1 CAT SRR INPP5F PPAT B3GAT1 EXOSC7 ATP2B1 ATP2B2 AGRN ATP2B3 ATP2B4 TGS1	1.48e-05	791	210	21	CID000023930
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A	NXPE3 PAPOLA CASKIN2 HS3ST3A1 RARA ALPK1 BTBD2 CAPRIN2 SMARCA2 PCNX1	1.48e-05	196	210	10	5005_DN
Drug	benzylthiourea	PDGFRA PDGFRB B3GAT1	1.52e-05	6	210	3	CID000737375
Drug	chloro-m-cresol	RYR1 RYR2 RYR3	1.52e-05	6	210	3	CID000012008
Drug	MBED	RYR1 RYR2 RYR3	1.52e-05	6	210	3	CID000129958
Drug	AC1O528X	RYR1 RYR2 RYR3	1.52e-05	6	210	3	CID006475857
Drug	NSC114784	RYR1 RYR2 RYR3	1.52e-05	6	210	3	CID000419425
Drug	sulfur monochloride	PDGFRA PDGFRB SYNE1	1.52e-05	6	210	3	CID000024807
Drug	AC1L88YH	ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.52e-05	17	210	4	CID000374551
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MYO9B ZNF230 RYR1 EHBP1L1 HIVEP3 OPTN PHF3 VCAN PCNX1 MYBPC3	1.55e-05	197	210	10	2860_UP
Drug	C070379	HK2 RYR1 RYR2 RYR3 CAT P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.69e-05	199	210	10	CID003034747
Drug	Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A	RYR1 NXPE3 NEK1 RBM19 C3 PLCD1 RALGDS RPS6KA4 PHF3 CTDP1	1.69e-05	199	210	10	2878_DN
Drug	fluo-3	RYR1 RYR2 RYR3 P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.79e-05	122	210	8	CID000104978
Drug	caffeine	CYP3A7 RCC2 RYR1 RYR2 RYR3 CHRND NEK4 RPTOR PLCD1 CACNA1A SYNE1 CAT P2RX7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	1.97e-05	562	210	17	CID000002519
Drug	myo-inositol	PDGFRA PDGFRB TEX2 RYR1 RYR2 RYR3 CHRND BPNT1 PLCD1 CACNA1A FBF1 CAT INPP5F RGS6 P2RX7 B3GAT1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SORD	2.14e-05	811	210	21	CID000000892
Drug	gramicidin s	MDH2 ATP2B1 ATP2B2 ATP2B3 ATP2B4	2.18e-05	37	210	5	CID000073357
Drug	adenosine diphosphoribose	MDH2 RYR1 RYR2 RYR3 RBM19 CAT P2RX7	2.32e-05	92	210	7	CID000030243
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR2 RYR3	2.63e-05	7	210	3	CID009547999
Drug	Azumoleno	RYR1 RYR2 RYR3	2.63e-05	7	210	3	CID000056259
Drug	Br2BAPTA	RYR1 RYR2 RYR3	2.63e-05	7	210	3	CID003081001
Drug	acetylenedicarboxylate	MDH2 C3 SEMA6A	2.63e-05	7	210	3	CID000000371
Drug	carbidine	CAT ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.22e-05	40	210	5	CID000065684
Drug	2brh	ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.72e-05	21	210	4	CID000848641
Drug	halothane	CYP3A7 RYR1 RYR2 RYR3 CHRND PLCD1 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4 SORD	3.77e-05	314	210	12	CID000003562
Drug	lanthanum	RYR1 RYR2 RYR3 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.93e-05	136	210	8	CID000023926
Drug	acronycine	UBA7 C3 SYNE1	4.19e-05	8	210	3	CID000345512
Drug	ritalinic acid	SRM ZNF331 CACNA1A	4.19e-05	8	210	3	CID000086863
Drug	L-beta-aspartyl phosphate	DBH CTDP1 ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.24e-05	69	210	6	CID000000832
Drug	linopirdine	KCNH7 ATP2B1 ATP2B2 ATP2B3 ATP2B4	4.61e-05	43	210	5	CID000003932
Drug	BAPTA	RYR1 RYR2 RYR3 RBM19 CACNA1A FN1 P2RX7 ATP2B1 ATP2B2 AGRN ATP2B3 ATP2B4	5.10e-05	324	210	12	CID000104751
Drug	verapamil	CYP3A7 KCNH7 ABCA12 RYR1 RYR2 RYR3 CHRND RPTOR MYO3B CACNA1A ABCC12 ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.37e-05	490	210	15	CID000002520
Drug	monobromobimane	MDH2 FLNB ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.40e-05	72	210	6	CID000114810
Drug	AC1L25Y6	ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.43e-05	23	210	4	CID000015465
Drug	divicine	C3 CAT ATP2B1 ATP2B2	5.43e-05	23	210	4	CID000091606
Drug	lanthanum chloride hydrate	ATP2B1 ATP2B2 ATP2B3 ATP2B4	5.43e-05	23	210	4	CID000165791
Drug	4,4'-dithiodipyridine	RYR1 RYR2 RYR3 RBM19 SEMA6A	5.76e-05	45	210	5	CID000075846
Drug	nimodipine	RYR1 RYR2 RYR3 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4	6.20e-05	145	210	8	CID000004497
Drug	pyranone	C3 SYNE1 CAT	6.24e-05	9	210	3	CID000119838
Drug	C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PSME4 PAPOLA MLLT3 DDX31 EML4 LARS2 EXOSC2 MRPL39 TGS1	6.26e-05	187	210	9	973_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SETX PSME4 PAPOLA MLLT3 CARD8 SPEN ATP2B1 ATP2B4 RBM41	6.53e-05	188	210	9	4845_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	ZBTB38 NEK1 CASKIN2 C3 PLCD1 RALGDS ALPK1 PHF3 VCAN	7.37e-05	191	210	9	6644_DN
Drug	cyhexatin	ATP2B1 ATP2B2 ATP2B3 ATP2B4	7.64e-05	25	210	4	CID005364545
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	PDGFRA RYR2 SYCP2 FN1 P2RX7 PHF3 VCAN TMEM209 ATP2B2	7.68e-05	192	210	9	1221_UP
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	ZNF273 SYTL2 ZNF230 SNX13 PRMT7 OPTN VCAN PCNX1 ELK3	7.99e-05	193	210	9	5088_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MYO9B SLC24A3 CASKIN2 CACNA1A SYNE1 LARS2 PHF3 CTDP1 AGRN	7.99e-05	193	210	9	3262_UP
Drug	dihydropyridine	RYR1 RYR2 RYR3 CACNA1A ATP2B1 ATP2B2 ATP2B3 ATP2B4 MYBPC3	7.99e-05	193	210	9	CID000104822
Drug	DCCD	HK2 RYR1 CFB SEMA6A ATP2B1 ATP2B2 ATP2B3 ATP2B4	8.24e-05	151	210	8	CID000010868
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A	MYO9B PDZD7 UBA7 RALGDS BTBD2 SBNO2 PHF3 CAPRIN2 TMEM209	8.31e-05	194	210	9	2397_DN
Drug	adenine	HK2 SRM MDH2 RYR1 RYR2 RYR3 BPNT1 PAPOLA C3 CAT PPAT P2RX7 MTHFD1 HPS5 SORD	8.40e-05	510	210	15	CID000000190
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	8.47e-05	2	210	2	ctd:C005147
Drug	caloxin 1b1	ATP2B1 ATP2B4	8.47e-05	2	210	2	ctd:C510327
Drug	5,7-Dmpq	PDGFRA PDGFRB	8.47e-05	2	210	2	CID000003139
Drug	3-pyridyl)urea	PDGFRA PDGFRB	8.47e-05	2	210	2	CID000202697
Drug	isocurcumenol	PDGFRA PDGFRB	8.47e-05	2	210	2	CID005255901
Drug	so36	CAT ELK3	8.47e-05	2	210	2	CID009577281
Drug	4-nitrophenylurea	PDGFRA PDGFRB	8.47e-05	2	210	2	CID000313520
Drug	1,2-dithiolan-3-one	DES CAT	8.47e-05	2	210	2	CID012723464
Drug	coccinelline	PUM2 TANC1	8.47e-05	2	210	2	CID000193710
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; HL60; HT_HG-U133A	PCDH17 SYCP2 PLCD1 FGFBP1 THSD7A SRR OPTN RGS6 RPL13	8.64e-05	195	210	9	2553_UP
Drug	WY-14643; Up 200; 100uM; MCF7; HG-U133A	MYO9B PLCD1 PRMT7 WDR13 RARA BTBD2 SBNO2 SMARCA2 PCNX1	8.64e-05	195	210	9	368_UP
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MYO9B MDH2 FCHO1 CASKIN2 DDX31 RPS6KA4 BTBD2 EXOSC2 TGS1	8.64e-05	195	210	9	7441_DN
Drug	Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A	CYP3A7 SVEP1 PCDH17 RYR2 FGFBP1 ADAMTSL3 HIVEP3 VCAN ATP2B4	8.64e-05	195	210	9	3401_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; HL60; HT_HG-U133A	PLCD1 CACNA1A FLNB DDX31 RPS6KA4 SRR ALPK1 ARAP3 CTDP1	8.64e-05	195	210	9	3119_DN
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B1 ATP2B2 ATP2B3 ATP2B4	3.77e-08	6	211	4	DOID:0050429 (implicated_via_orthology)
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2 RYR3	3.61e-07	3	211	3	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2 RYR3	3.61e-07	3	211	3	DOID:8545 (implicated_via_orthology)
Disease	Colorectal Carcinoma	ABCA12 BUB1B VPS13A MKI67 RALGDS FLNC RELCH NRAS FN1 SYNE1 CAPN6 ADAMTSL3 HIVEP3 ARAP3 P2RX7 SETBP1 LAS1L	1.35e-05	702	211	17	C0009402
Disease	cerebellar ataxia (implicated_via_orthology)	AARS2 VPS13A CACNA1A	1.97e-05	8	211	3	DOID:0050753 (implicated_via_orthology)
Disease	hypertension (biomarker_via_orthology)	HK2 PDGFRA PDGFRB DBH C3 PLCD1 FN1 CAT ATP2B1	4.04e-05	227	211	9	DOID:10763 (biomarker_via_orthology)
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	RYR2 DES TMEM43	4.17e-05	10	211	3	DOID:0050431 (is_implicated_in)
Disease	membranoproliferative glomerulonephritis (is_implicated_in)	CFB FN1	5.09e-05	2	211	2	DOID:2920 (is_implicated_in)
Disease	erythema nodosum (is_marker_for)	CFB C3	5.09e-05	2	211	2	DOID:0080750 (is_marker_for)
Disease	boutonneuse fever (is_marker_for)	CFB C3	5.09e-05	2	211	2	DOID:14095 (is_marker_for)
Disease	anterior uveitis (is_marker_for)	CFB C3	5.09e-05	2	211	2	DOID:1407 (is_marker_for)
Disease	conjunctivitis (is_marker_for)	CFB C3	5.09e-05	2	211	2	DOID:6195 (is_marker_for)
Disease	Schizophrenia	PDGFRB MYO9B PCDH17 ATXN2 RARA HNRNPA3 SRR IDE LARS2 ADAMTSL3 SBNO2 NPTN IGF2BP2 SBNO1 MTHFD1 SMARCA2 B3GAT1 PCNT	7.15e-05	883	211	18	C0036341
Disease	Malignant neoplasm of breast	CHRND DDX10 DES MKI67 HERC2 FLNB RARA FN1 TCP1 SYNE1 MANEA CAT KMT2D ARAP3 SBNO1 SETBP1 FAM217B MACF1 ELK3 SPEN	9.74e-05	1074	211	20	C0006142
Disease	colorectal cancer	ABCA12 ATXN2 FMN1 HERC2 PIWIL4 SBNO2 VCAN CAPRIN2 MACF1 PCNX1 TANC1 TOX2 TTC33 PCNT	1.25e-04	604	211	14	MONDO_0005575
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	1.52e-04	3	211	2	DOID:0080096 (implicated_via_orthology)
Disease	complement C3D fragment measurement	CFB C3	1.52e-04	3	211	2	EFO_0020277
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	1.52e-04	3	211	2	DOID:0111190 (implicated_via_orthology)
Disease	late-onset Alzheimers disease	ADAM18 BSG USP32 ADAMTS20 MLLT3 HS3ST3B1 CACNA1A NRAS AGRN	2.71e-04	292	211	9	EFO_1001870
Disease	mean arterial pressure	MYO9B DBH ZNF831 SVEP1 CEP170 ATXN2 RPTOR HIVEP3 ARAP3 RGS6 ATP12A ATP2B1	2.73e-04	499	211	12	EFO_0006340
Disease	lepromatous leprosy (is_marker_for)	CFB C3	3.02e-04	4	211	2	DOID:10887 (is_marker_for)
Disease	factor VIII deficiency (is_marker_for)	CFB C3	3.02e-04	4	211	2	DOID:12134 (is_marker_for)
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 TMEM43	3.02e-04	4	211	2	cv:CN293514
Disease	white matter hyperintensity measurement	HK2 ZNF831 CHD6 HS3ST3A1 FBF1 VCAN SETBP1 SUMO2 SORD	3.47e-04	302	211	9	EFO_0005665
Disease	lymphocyte count	CYP3A7 ZBTB38 GIGYF1 ZNF831 PSME4 ATXN2 OSBPL7 C3 FGFBP1 LETM2 FLNB FRAS1 FN1 SBNO2 IGF2BP2 SBNO1 MTHFD1 ADGRD2 SSH2 AGBL2 ATP2B4 FAM177A1 PHTF1	3.52e-04	1464	211	23	EFO_0004587
Disease	Cardiomyopathies	RYR2 DES NRAS CAT TMEM43 MYBPC3	3.56e-04	130	211	6	C0878544
Disease	IgA glomerulonephritis (is_marker_for)	CFB C3 FN1	3.76e-04	20	211	3	DOID:2986 (is_marker_for)
Disease	unipolar depression, mood disorder	PCDH17 UBA7 THSD7A MYO1H ARHGAP27 AGBL2	4.18e-04	134	211	6	EFO_0003761, EFO_0004247
Disease	Malignant Cystosarcoma Phyllodes	RARA KMT2D	5.02e-04	5	211	2	C0600066
Disease	Mesenchymal Chondrosarcoma	PDGFRA MKI67	5.02e-04	5	211	2	C0206637
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 TMEM43	5.02e-04	5	211	2	C0410190
Disease	oligohydramnios (biomarker_via_orthology)	PDGFRA PDGFRB	5.02e-04	5	211	2	DOID:12215 (biomarker_via_orthology)
Disease	Phyllodes Tumor	RARA KMT2D	5.02e-04	5	211	2	C0010701
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 TMEM43	5.02e-04	5	211	2	C1450051
Disease	Myelomonocytic leukemia	NRAS SETBP1	5.02e-04	5	211	2	C0027019
Disease	alcohol use disorder (implicated_via_orthology)	DBH RYR1 RYR2 RYR3 CHRND SMARCA2 SSH2	5.32e-04	195	211	7	DOID:1574 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	PSKH1 SNX13 EHBP1L1 ATXN2 MOGAT2 MACF1	6.12e-04	144	211	6	EFO_0004611, EFO_0020943
Disease	phenylalanine measurement	WASHC4 LARS2 ATP2B2 ATP2B4	6.52e-04	55	211	4	EFO_0005001
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 TMEM43	7.49e-04	6	211	2	cv:C0410189
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	RYR1 CHRND	7.49e-04	6	211	2	C1854678
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 TMEM43	7.49e-04	6	211	2	C0410189
Disease	Myofibrillar myopathy	DES FLNC	7.49e-04	6	211	2	cv:C2678065
Disease	migraine with aura (is_implicated_in)	DBH CACNA1A	7.49e-04	6	211	2	DOID:10024 (is_implicated_in)
Disease	Amyotrophic Lateral Sclerosis	SETX NEK1 ATXN2 OPTN	7.97e-04	58	211	4	C0002736
Disease	testosterone measurement	CYP3A7 MAP1A MYO9B SLC24A3 CDCA2 NRAS EML4 RGS6 SYTL4 MTHFD1 AOPEP C18orf63 SMARCA2 MACF1 RIMBP2 ATP12A MYO15A ATP2B2 ATP2B4 SORD	8.78e-04	1275	211	20	EFO_0004908
Disease	QRS-T angle	RYR2 DES PCNX1 AGBL2 MYBPC3	1.01e-03	106	211	5	EFO_0020097
Disease	ER membrane protein complex subunit 4 measurement	CFB C3	1.04e-03	7	211	2	EFO_0801580
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 TMEM43	1.04e-03	7	211	2	C0751337
Disease	familial hemiplegic migraine (implicated_via_orthology)	CACNA1A ATP12A	1.04e-03	7	211	2	DOID:0060178 (implicated_via_orthology)
Disease	alkaline phosphatase measurement	MAP1A PSKH1 DBH SNX13 ATXN2 CASKIN1 RALGDS MOGAT2 SBNO2 HIVEP3 RGS6 P2RX7 MACF1 B3GAT1 NRSN1 PHTF1 MYBPC3	1.07e-03	1015	211	17	EFO_0004533
Disease	Amyotrophic Lateral Sclerosis With Dementia	NEK1 ATXN2 OPTN	1.15e-03	29	211	3	C0393554
Disease	serum albumin measurement	MAP1A SVEP1 SNX13 EHBP1L1 ATXN2 NRAS MOGAT2 IGF2BP2 SBNO1 MACF1 PCNT MYBPC3	1.22e-03	592	211	12	EFO_0004535
Disease	Leydig cell tumor (is_marker_for)	PDGFRA PDGFRB	1.39e-03	8	211	2	DOID:2696 (is_marker_for)
Disease	Sudden Cardiac Arrest	TMEM43 MYBPC3	1.39e-03	8	211	2	C1720824
Disease	Sudden Cardiac Death	TMEM43 MYBPC3	1.39e-03	8	211	2	C0085298
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFB C3	1.39e-03	8	211	2	DOID:0080301 (is_implicated_in)
Disease	Amyotrophic Lateral Sclerosis, Guam Form	NEK1 ATXN2 OPTN	1.40e-03	31	211	3	C0543859
Disease	congenital heart disease (implicated_via_orthology)	CHD6 KMT2D RPL13 MYBPC3	1.53e-03	69	211	4	DOID:1682 (implicated_via_orthology)
Disease	Diabetes Mellitus	FN1 CAT ALPK1	1.53e-03	32	211	3	C0011849
Disease	keratinocyte carcinoma	RCC2 SNX13 HERC2 SBNO2 PHTF1	1.62e-03	118	211	5	EFO_0010176
Disease	prostate cancer (implicated_via_orthology)	PDGFRB MEP1A NRAS	1.68e-03	33	211	3	DOID:10283 (implicated_via_orthology)
Disease	Atypical hemolytic-uremic syndrome	CFB C3	1.77e-03	9	211	2	cv:C2931788
Disease	tumor necrosis factor ligand superfamily member 14 measurement	CFB C3	1.77e-03	9	211	2	EFO_0010613
Disease	C3 glomerulopathy	CFB C3	1.77e-03	9	211	2	C4087273
Disease	Hemolytic-uremic syndrome	CFB C3	1.77e-03	9	211	2	cv:C0019061
Disease	Gout	ALPK1 CARD8	1.77e-03	9	211	2	C0018099
Disease	sleep duration, high density lipoprotein cholesterol measurement	PSKH1 SNX13 MYO1H SBNO1 MACF1	1.81e-03	121	211	5	EFO_0004612, EFO_0005271
Disease	calcium measurement	MAP1A EHBP1L1 CASKIN2 PARP15 NRAS SYTL4 AOPEP MACF1 ABCC12 AGBL2 TOX2 ATP2B1	2.00e-03	628	211	12	EFO_0004838
Disease	Atypical Hemolytic Uremic Syndrome	CFB C3	2.21e-03	10	211	2	C2931788
Disease	thyroid gland papillary carcinoma (is_implicated_in)	NRAS KMT2D	2.21e-03	10	211	2	DOID:3969 (is_implicated_in)
Disease	Bipolar Disorder	DBH NEK4 MLLT3 CACNA1A THSD7A SYNE1 LARS2 P2RX7 MTHFD1 PCNT	2.42e-03	477	211	10	C0005586
Disease	basal cell carcinoma	RCC2 SNX13 HERC2 SBNO2 MYO15A PHTF1	2.46e-03	189	211	6	EFO_0004193
Disease	birth weight, parental genotype effect measurement	CYP3A7 ZBTB38 ATXN2 RPS6KA4 ARAP3 CAPRIN2	2.66e-03	192	211	6	EFO_0004344, EFO_0005939
Disease	Paranoia	DBH MANEA	2.68e-03	11	211	2	C1456784
Disease	Hemolytic-Uremic Syndrome	CFB C3	2.68e-03	11	211	2	C0019061
Disease	pro‐interleukin‐16 measurement	MLLT3 ADAMTSL3	2.68e-03	11	211	2	EFO_0010629
Disease	unipolar depression	CFB CDCA2 BPNT1 FMN1 CHD6 ACSS3 PARP15 THSD7A MYO1H ADCK1 MANEA IHO1 ARAP3 MICAL2 ASXL3 VCAN SMARCA2 CDH18	2.71e-03	1206	211	18	EFO_0003761
Disease	kynurenine measurement	PLEKHH1 ATXN2 THSD7A	2.73e-03	39	211	3	EFO_0008529
Disease	PR interval	ABCA12 RYR2 CASKIN2 CHD6 EML4 CCDC7 HIVEP3 IGF2BP2 MICAL2 MACF1	3.14e-03	495	211	10	EFO_0004462
Disease	asparagine measurement	A2ML1 FRAS1 PIWIL4	3.15e-03	41	211	3	EFO_0009766
Disease	congestive heart failure (implicated_via_orthology)	MDH2 RYR2 PLCD1	3.15e-03	41	211	3	DOID:6000 (implicated_via_orthology)
Disease	Secondary Open Angle Glaucoma	ATXN2 OPTN	3.20e-03	12	211	2	C0271148
Disease	hair colour measurement, hair morphology measurement	HERC2 RPL13	3.20e-03	12	211	2	EFO_0007821, EFO_0007822
Disease	cleft palate (is_implicated_in)	FLNB MTHFD1	3.20e-03	12	211	2	DOID:674 (is_implicated_in)
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	3.20e-03	12	211	2	DOID:10941 (is_implicated_in)
Disease	event free survival time, type 1 diabetes mellitus, autoantibody measurement	ATXN2 PHTF1	3.20e-03	12	211	2	EFO_0000482, EFO_0004866, MONDO_0005147
Disease	Glaucoma, Open-Angle	ATXN2 OPTN	3.20e-03	12	211	2	C0017612
Disease	colorectal health	RYR2 DDX10 HERC2 HS3ST3B1 EML4 ADAMTS5	3.34e-03	201	211	6	EFO_0008460
Disease	sporadic amyotrophic lateral sclerosis	RBM19 RGS6 ABCC12 ATP2B2 ATP2B4	3.41e-03	140	211	5	EFO_0001357
Disease	ascending aortic diameter	SLC24A3 RYR2 FLNB HIVEP3 ATP2B1	3.41e-03	140	211	5	EFO_0021787
Disease	cataract	SLC24A3 HERC2 THSD7A CAPRIN2 PCNT	3.51e-03	141	211	5	MONDO_0005129
Disease	Adenocarcinoma of lung (disorder)	HK2 SRM NEK1 NRAS EML4 SRR	3.77e-03	206	211	6	C0152013
Disease	Short Rib-Polydactyly Syndrome	NEK1 DYNC2I2	3.77e-03	13	211	2	C0036996
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	C3 RARA	3.77e-03	13	211	2	DOID:332 (biomarker_via_orthology)
Disease	Glaucoma, Primary Open Angle	ATXN2 OPTN	3.77e-03	13	211	2	C0339573
Disease	Fetal Alcohol Spectrum Disorders	PDGFRA CAT	3.77e-03	13	211	2	C2985290
Disease	cortical surface area measurement	MYO9B SVEP1 SNX13 ATXN2 ADAMTS20 MLLT3 SEMA6A HS3ST3B1 CACNA1A FLNB NCAPD3 ADAMTSL3 ITIH5 AOPEP VCAN MACF1 ELK3 SSH2 ARHGAP27	3.79e-03	1345	211	19	EFO_0010736
Disease	neuritic plaque measurement	SLC24A3 SVEP1 RYR3 HS3ST3B1 CACNA1A MANEA ALPK1 SMARCA2	3.79e-03	349	211	8	EFO_0006798
Disease	left ventricular systolic function measurement	SNX13 ATXN2 FLNC	3.85e-03	44	211	3	EFO_0008206
Disease	age at diagnosis, osteonecrosis	ABCA12 ZNF331 IGF2BP2	3.85e-03	44	211	3	EFO_0004259, EFO_0004918

Protein segments in the cluster

Peptide	Gene	Start	Entry
SINHILSTRKPGKEE	BUB1B	361	O60566
HTRTEKPVLVNEGKK	B3GAT1	311	Q9P2W7
SAKTARKPDHTTVDI	CACNA1A	1156	O00555
KFTSVPRKDVHEITS	ARID4B	221	Q4LE39
DSTPGKVTIRDHVTK	CEP170	286	Q5SW79
RKKVNHSRGTEVSEP	CTDP1	341	Q9Y5B0
RTPSTHVLSEGVKKL	CHRND	336	Q07001
DGRTVAVKVQHPKVR	ADCK1	176	Q86TW2
PDKKEHLVLVETGRT	ARAP3	866	Q8WWN8
PGAVTEHKVKTDEVV	VCAN	1106	P13611
EHKVKTDEVVTLTPR	VCAN	1111	P13611
EHIGKKTPIAVRFST	CAT	101	P04040
GPITTQLKSHRETDK	CCDC7	1191	Q96M83
TDVVRIPEGATHIKV	ADAMTS5	746	Q9UNA0
IPEGATHIKVRQFKA	ADAMTS5	751	Q9UNA0
ARVHGIPEKDIKETV	ABCA12	2356	Q86UK0
RAQVRKKPTVEGFTH	MLLT3	16	P42568
HVTVPRKIKSNDSEV	ADAM18	26	Q9Y3Q7
REHIKGKETTPSSLA	FGFBP1	171	Q14512
VLVKPEGVLVEKTHS	A2ML1	901	A8K2U0
VLGESPKSRKVPHTV	AGRN	1746	O00468
KEHLPVTKIVITDTG	CNTNAP4	756	Q9C0A0
TVTVHDFPGKKLVLS	C3	56	P01024
QVLRPSKDKTGHTSD	AOPEP	551	Q8N6M6
SSVKHLKPGDRVAIE	SORD	81	Q00796
QLKEVPAGKHIITTT	BPNT1	181	O95861
ISKVSTHKGAELPRE	ECD	461	O95905
ARSSPTDKHTLVKGI	ATP2B1	766	P20020
SSPTDKHTLVKGIID	ATP2B2	791	Q01814
SPTDKHTLVKGIIDS	ATP2B3	766	Q16720
SSPTDKHTLVKGIID	ATP2B4	756	P23634
TLPHIEVKIEGKSES	ASXL3	511	Q9C0F0
RVLGHTSKNVPLKDE	ADAMTS20	231	P59510
SARKEPGKEHLVDTQ	ALPK1	606	Q96QP1
SANVTIRKGPHEKEL	CKAP2	276	Q8WWK9
IVKTNSHEPGKREKR	MKRN2	91	Q9H000
TEPEHTKERVKLEGS	RCC2	86	Q9P258
PTRTVDTKQAHELAK	NRAS	121	P01111
GHKLEVRISERATKP	RBM19	801	Q9Y4C8
HVSGEKKTKLRATPE	RBM41	101	Q96IZ5
TPVVELVVKVTDHGK	PCDH17	656	O14917
LVVKVTDHGKPTLSA	PCDH17	661	O14917
TPEVGELIEKVRKAH	RARA	181	P10276
HDKGVKRTAEVPVSE	RFX5	426	P48382
VHVLSQPIRKTTKED	RGS6	246	P49758
THSKGKETIAIRPAA	FMN1	346	Q68DA7
EHGRPEDKSKIVSEI	PUM2	931	Q8TB72
QAKISVIRPSKGHES	CFB	496	P00751
TISVHEKGFIEIKPT	PDGFRA	306	P16234
SKAKLHGEVPQIEVT	RELCH	771	Q9P260
HSVKQGPISTKELAD	FCHO1	21	O14526
KKSPRSIVEDIHQGK	FHDC1	186	Q9C0D6
VTKPGHRKKIAAEIS	CASKIN1	516	Q8WXD9
EPGRVATVLASVKHK	CASKIN1	1036	Q8WXD9
IHVPGGKDVRKTVTS	PARP15	376	Q460N3
QVQTGHKPSTKEIVR	LETM2	261	Q2VYF4
EHKITVQASPTLDKR	MAP3K10	481	Q02779
VSEDAGTVKIPVIRH	FRAS1	2806	Q86XX4
VKEKEGVLHVPITRS	FRAS1	2926	Q86XX4
SGSKVVPAHLSRKTE	H1-8	306	Q8IZA3
KTKGRTHPEIDREVV	HS3ST3B1	351	Q9Y662
QKVRSVEHKAPEDTV	MAP1A	1501	P78559
SHLSGRPIRKKTEEE	GIGYF1	871	O75420
TTERHTVGEVIKLGP	NEK1	781	Q96PY6
KKVPRRVIHFVSGET	FAM177A1	51	Q8N128
IKISKTSVDGDPHFV	ITIH5	671	Q86UX2
SKREVVAVGHLEVPA	MYO15A	1991	Q9UKN7
EQVKHRTLPKSVVDV	HERC2	1466	O95714
PREHLVIKQKDGTVE	IHO1	421	Q8IYA8
PKVKDRTHNVTEKVT	KCNH7	361	Q9NS40
STIPITAEVFKKHGV	MDH2	146	P40926
VTGDHPITAKAIAKS	ATP12A	631	P54707
SKAENKGISPVVSEH	ATXN2	776	Q99700
KGISPVVSEHRKQID	ATXN2	781	Q99700
RKTTEKIGTLHTSPD	HPS5	551	Q9UPZ3
KHFITEVDSVGPVKA	PSKH1	36	P11801
RSTKLKKHPRGETEV	DYNC2I2	321	Q96EX3
ERGLSKETHASAPVK	HK2	496	P52789
ITDQEGKPKRAIVHD	FLNB	1556	O75369
KAHLVPEGTSKKRAT	PCNX1	661	Q96RV3
TSEHKVGRDSPVNKL	PLXNB3	1796	Q9ULL4
SDIIHSVRVEKSPAG	PDZD7	81	Q9H5P4
HPIVGKVDVTSTQKE	NEK4	571	P51957
RTKNIEKSPTVTKDH	FAM205C	291	A6NFA0
KVETSGHIRVPKQAA	FAM217B	316	Q9NTX9
ERIADIKAHTQPVTK	NRSN1	156	Q8IZ57
TPKEVGEHVVSVRKS	FLNC	2006	Q14315
AEQRSKVRHVDTKGP	EHBP1L1	426	Q8N3D4
KVRHVDTKGPEATGV	EHBP1L1	431	Q8N3D4
TVRSGHVAKKKPEES	KIF24	651	Q5T7B8
KEVTSTVLHGKVPLA	MACF1	1381	O94854
TEVQRGEGTDPKSHK	LAS1L	351	Q9Y4W2
ELLTERSSPKGGHVK	POLG2	31	Q9UHN1
KTKGRTHPEIDREVV	HS3ST3A1	366	Q9Y663
KCTVPGHKSIEERVT	JRKL	196	Q9Y4A0
PEIIRSKTGHGKAVD	RPS6KA4	206	O75676
RKENSGAAEKPVTIH	IGF2BP2	231	Q9Y6M1
HTEELVAAGKTTKIP	MKI67	1236	P46013
ISTPGRLVDHIKSTK	DDX31	361	Q9H8H2
DTKKHLVVPGDTITT	EXOSC2	21	Q13868
QSVVHKEESLGPKRQ	EXOSC7	271	Q15024
HLGVFPSKAERKITS	PCNT	3176	O95613
EDLTAIGVTKPGHRK	CASKIN2	526	Q8WXE0
NGESEVAIKIPIKHT	SLC24A3	366	Q9HC58
HEGTQIEKAVPKRTS	MANEA	406	Q5SRI9
GEHKAQVTTKAEVEP	PIPSL	436	A2A3N6
IVDPKVTVEIHGVSR	PLCD1	651	P51178
IVGVKRTSSPHKEES	PAPOLA	646	P51003
EKDGVIQTKVKHRTP	OSBPL8	761	Q9BZF1
TTVVGKPIEVQKTLH	MOGAT2	281	Q3SYC2
PVISSVHTKVKGIAE	P2RX7	56	Q99572
KPVKLASHTRDTTGV	FBF1	16	Q8TES7
IKVINKHSTEVTVGP	PRMT7	116	Q9NVM4
KILASKTVQEVHPGE	CHD6	296	Q8TD26
KVFAVSHGRESKPLT	FN1	976	P02751
PNGHTKKSVSFREIV	ARFGEF3	1701	Q5TH69
TSPEQRGSEVHTKKT	DES	431	P17661
KKVVSVHPGDVLITS	DBH	451	P09172
PRVKAVKSSEHINEG	BSG	221	P35613
KEPIQLEITEKRHGT	CARD8	411	Q9Y2G2
AKKAVVLSARVHPGE	AGBL2	451	Q5U5Z8
SGKHQEVSKPAVSLE	CAPRIN2	426	Q6IMN6
VTNKTDKHVTRPVVS	ELK3	186	P41970
KGKEHLAPTIRATVT	RALGDS	421	Q12967
NHEKISSPKVGRITR	CDCA2	491	Q69YH5
KPGQVIHTISATDKD	CDH18	501	Q13634
AIKRIGNHITKSPED	IDE	46	P14735
KRVELKTPLGDTTHT	IGHG3	96	P01860
RKPSHTSAVSIAGKE	EML4	91	Q9HC35
SEVEDVGPTSHNRKK	DDX10	831	Q13206
KVESHVRFSPLKSGE	CCDC168	1626	Q8NDH2
RREAETGKPVTLKHV	CYP3A7	161	P24462
KGLRKVTHESPTTGA	BTBD2	481	Q9BX70
GKEEVRSPVQKNTVH	CAPN6	546	Q9Y6Q1
VSKVEGEIKHVETPL	C4orf54	721	D6RIA3
KSSKPHEDIIGIRSQ	INPP5F	751	Q9Y2H2
KIGLRHPDAVVETSS	SBNO1	251	A3KN83
HLEAVVSSGRVEKSP	RYR1	2976	P21817
TIHPASKQRSEGEKV	RYR2	161	Q92736
KATHIKLPRTTTESE	MTHFD1	66	P11586
SVLGSPKRKQHDVTQ	C18orf63	451	Q68DL7
IHKKVARTIGISVDP	RPL13	86	P26373
PESVHLKAGERISQK	MICAL2	1461	O94851
VTDPQLVVTLHEKKG	PDGFRB	151	P09619
PTHQASVTTERPKKG	OSBPL7	231	Q9BZF2
SVKEIKHSPGPTRTV	OPTN	191	Q96CV9
SGNPRKHITSLKEAV	GTF2H2C;	121	Q6P1K8
KSKIVSPGLTIHERI	SYTL2	296	Q9HCH5
RHKPAVSKRETVGQS	SYTL4	141	Q96C24
PDELKHIIGAETTRK	SNX13	886	Q9Y5W8
VGKDVVVAPSHLRVD	RIMBP2	386	O15034
RTEKIEVKHVGKTDP	MRPL39	61	Q9NYK5
RREHVKVKTSSQPGF	TMEM43	11	Q9BTV4
SDLPVKVTHTETGKV	SMARCA2	591	P51531
DKRGDVKTSRAVHPT	THSD7A	1566	Q9UPZ6
VLSHEPSVKSVREKG	SYNE1	3866	Q8NF91
EVDLTGSVPVHAKTK	LARS2	616	Q15031
GSVPVHAKTKEKLEV	LARS2	621	Q15031
QVKKEDHEATGPRLS	NBPF14	266	Q5TI25
QVKKEDHEATGPRLS	NBPF26	266	B4DH59
VKVSVSLVHPSEGIR	NXPE3	181	Q969Y0
ITHLSQTEVPTKGKR	MEP1A	596	Q16819
GPVGLESDLSKVRHK	ARHGAP27	656	Q6ZUM4
KPTHTFQKRDGTEIT	PIWIL4	321	Q7Z3Z4
VKKGAEGIEEHTRPR	SETX	1131	Q7Z333
DIPVKGSHSTKVEAV	SHPRH	1501	Q149N8
ELVKQKIHPTSVISG	TCP1	106	P17987
GPDTRIKDKVVTHVQ	TANC1	1696	Q9C0D5
KIGKQHPDRVVETST	SBNO2	211	Q9Y2G9
TKAKRLVVHEGSPVT	WDR13	341	Q9H1Z4
SEGIHSSKEKPLVAV	RNF169	466	Q8NCN4
ALERKPKAVVTHSSG	SRR	71	Q9GZT4
GIEQVKHRTLPKSVV	HERC2P3	191	Q9BVR0
PTAKDNSGEKVSVHV	SVEP1	591	Q4LDE5
VARVGPEKASLSHVV	ABCC12	101	Q96J65
SIGIVIKHRIPEKAS	SLC10A5	286	Q5PT55
ERHSKGPLIVDTVSA	AARS2	876	Q5JTZ9
KASLQKRPDGHIVSV	RPTOR	1216	Q8N122
SREKIKSDHPGISIT	SSRP1	561	Q08945
LVAGVPKSERTTVHK	ADGRD2	681	Q7Z7M1
ELSSRIDHVKPKVVV	ACSS3	206	Q9H6R3
EHVTKRAISTPEKSI	NCAPD3	1406	P42695
STLTEHKRVHTGEKP	ZNF273	471	Q14593
GHLKVTSKSRSELPD	VPS13A	676	Q96RL7
KERSDIPSGTSKHLQ	USP16	426	Q9Y5T5
TRVKEKEGKVIDHTP	SPEN	881	Q96T58
IKSLSHSPGVVKERA	SSH2	1221	Q76I76
HSPGVVKERAKEIES	SSH2	1226	Q76I76
NTLHSGTKRDPKEDV	PHTF1	406	Q9UMS5
GAITEVKRPKTVRHK	UBA7	251	P41226
TIHPASKQRSEGEKV	RYR3	151	Q15413
LGESPTLRTVKHDSK	SEMA6A	201	Q9H2E6
VGPRNHDELKSSVKT	SYCP2	906	Q9BX26
TIEVKAAPDITGHKR	NPTN	231	Q9Y639
KESGAKEVHIRVASP	PPAT	406	Q06203
VLTSTEDGKRPEKSH	HIVEP3	1471	Q5T1R4
SSLVKHERIHTGVKP	ZNF331	396	Q9NQX6
ERRPITKITHKGEIE	PHF3	1046	Q92576
DGSVVQFKIKRHTPL	SUMO2	26	P61956
VSREDSVKPGAHLTV	HNRNPA3	111	P51991
GVLREVVKHPSVESV	SRM	106	P19623
SVGDTIPSAELVKRH	PSME4	1746	Q14997
VIRSIPDKSSGKSHI	PLEKHH1	1286	Q9ULM0
EKQHRVKLGSPDSTS	TMEM209	251	Q96SK2
HQRVPTGEKSVKSLE	ZNF229	311	Q9UJW7
SKLIEHIRTHTGEKP	ZNF786	661	Q8N393
SEVHFKISGEKRPSA	TOX2	221	Q96NM4
SNKIAPKIIETTGVH	WASHC4	171	Q2M389
LQTRERVHTGEKPFK	ZNF230	211	Q9UIE0
PEEGKTKRVHASFTR	ZBED9	721	Q6R2W3
EKKKTTSHTRGEIPE	ZBTB38	776	Q8NAP3
SVTPEKIAEHIAGRV	TGS1	671	Q96RS0
DKRTVKDISPSAGEH	ZNF831	1391	Q5JPB2
SKIIGEESGSHRPKA	TEX2	306	Q8IWB9
KEADHEIPTVSGSRK	SLC6A14	626	Q9UN76
KKQPLLTVETIHEGT	SETBP1	591	Q9Y6X0
AEIIIPGITSKFHTK	SLC36A4	371	Q6YBV0
IANSSKIDRHKVPTE	USP32	716	Q8NFA0
STLRKHEIIHTGEKP	ZNF729	361	A6NN14
SSLVKHERIHTGEKP	ZNF283	276	Q8N7M2
AQRIKKSEAPAEVTH	TTC33	181	Q6PID6
RGQSKSHVSPEKREE	ADAMTSL3	231	P82987
SHTRTKKGPAAQAEV	KMT2D	1706	O14686
ILVIHVSPEDSKQKG	MYO1H	946	Q8N1T3
AGKAKVDTLEVIRHP	MYO3B	906	Q8WXR4
KTVAAESHEKVPSSR	MYO9B	1131	Q13459
GKELVPDSRIKVSHI	MYBPC3	581	Q14896